| | |
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations |
Overview
The following overview is qualified in its entirety by the more complete discussion contained in this Item 7, the risk factors set forth in Item 1A of this Form 10-K, and our consolidated financial statements and the notes thereto set forth in Item 8 of this Form 10-K. Please also see the cautionary language at the beginning of Part I of this Annual Report on Form 10-K regarding forward-looking statements.
Fiscal 2023 Financial Performance Summary
The following table sets forth some of our key consolidated financial information for each of our last three fiscal years:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
| (in millions, except per share amounts) |
Revenue | $ | 5,842.6 | | | $ | 5,081.5 | | | $ | 4,204.2 | |
Cost of revenue | $ | 1,222.2 | | | $ | 1,063.7 | | | $ | 861.8 | |
Operating expenses | $ | 3,351.2 | | | $ | 2,855.8 | | | $ | 2,607.6 | |
Operating income | $ | 1,269.3 | | | $ | 1,162.0 | | | $ | 734.8 | |
Net income attributed to Synopsys | $ | 1,229.9 | | | $ | 984.6 | | | $ | 757.5 | |
Diluted net income per share attributed to Synopsys | $ | 7.92 | | | $ | 6.29 | | | $ | 4.81 | |
Fiscal 2023 compared to fiscal 2022 financial performance summary
•Revenues were $5.8 billion, an increase of $761.1 million or 15%, primarily due to revenue growth across all products and geographies.
•Total cost of revenue and operating expenses was $4.6 billion, an increase of $653.9 million or 17%, primarily due to an increase of $287.7 million in employee-related costs resulting from headcount increases through organic growth and acquisitions.
•Operating income was $1.3 billion, an increase of $107.2 million or 9%.
For a summary of fiscal 2022 comparison to fiscal 2021, see the discussion in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended October 31, 2022, filed on December 12, 2022.
Business Summary
Synopsys provides products and services used across the entire Silicon to Software spectrum to bring Smart Everything to life. From engineers creating advanced semiconductors to product teams developing advanced electronic systems to software developers seeking to ensure the security and quality of their code, our customers trust that our technologies will enable them to meet new requirements for energy efficiency, reliability, mobility, security and more. For more information about our business segments and product groups, see Part I, Item 1 Business of this Annual Report on Form 10-K.
We have consistently grown our revenue since 2005, despite periods of global economic uncertainty. We achieved these results because of our solid execution, leading technologies and strong customer relationships, and because we generally recognize our revenue for software licenses over the arrangement period, which typically approximates three years. See Note 2. Summary of Significant Accounting Polices and Basis of Presentation of the Notes to Consolidated Financial Statements in this Annual Report on Form 10-K for a discussion on our revenue recognition policy. The revenue we recognize in a particular period generally results from selling efforts in prior periods rather than the current period. As a result, decreases as well as increases in customer spending do not immediately affect our revenues in a significant way.
Our growth strategy is based on maintaining and building on our leadership in our Design Automation products, expanding and proliferating our Design IP offerings and continuing to expand our product portfolio and our total addressable market. Our revenue growth from period to period is expected to vary based on the mix of our time based and upfront products. Based on our leading technologies, customer relationships, business model, diligent
expense management, and acquisition strategy, we believe that we will continue to execute our strategies successfully.
Recent Developments
Impact of the Current Macroeconomic and Geopolitical Environment
Uncertainty in the macroeconomic environment, including the effects of, among other things, increased global inflationary pressures and interest rates, potential economic slowdowns or recessions, supply chain disruptions, geopolitical pressures, fluctuations in foreign exchange rates, and associated global economic conditions, have resulted in volatility in credit, equity and foreign currency markets. We expect growth across our geographies in fiscal 2024; however, we are expecting a challenging near-term growth environment in China due to macroeconomic factors as well as, to a lesser degree, entity list and trade restrictions as further discussed below and in Part I, Item 1A, Risk Factors of this Annual Report on Form 10-K.
The current uncertain macroeconomic environment could lead some of our customers to postpone their decision-making, decrease their spending and/or delay their payments to us. For more on risks related to the current macroeconomic and geopolitical environment, see Part I, Item 1A, Risk Factors, “Uncertainty in the macroeconomic environment, and its potential impact on the semiconductor and electronics industries, may negatively affect our business, operating results and financial condition” of this Annual Report on Form 10-K. For example, we continue to experience an impact from the current macroeconomic environment in our Software Integrity segment as customers have applied elevated levels of scrutiny to purchasing decisions due in part to their own budget uncertainty, which has, in some cases, affected customer order size, pricing and/or contract duration. While the situation is dynamic, we expect customers to continue to scrutinize their budgets and negotiate orders for our Software Integrity segment products and solutions in light of the current macroeconomic environment. Further, following a strategic portfolio review, and in consultation with our Board of Directors, we have decided to explore strategic alternatives for our Software Integrity segment. As a part of this process, our management is considering a full range of strategic opportunities. At this time we cannot predict the impact that such strategic alternatives might have on our business, operations or financial condition.
We are also actively monitoring geopolitical pressures around the world, including, among others, changes in the China-Taiwan relations, the conflicts in Ukraine, the Middle East and other regional or global military conflicts. Any significant disruption caused by these or other geopolitical pressures or conflicts could materially affect our employees, business, operating results, financial condition or customers in those regions of the world. For example, Synopsys has employees, operations, customers and strategic partners in the Middle East and in Armenia, which are each experiencing geopolitical conflicts. While we are actively monitoring these conflicts, at this time, these geopolitical conflicts have not had a material impact on our business, financial condition, or results of operations.
While our time-based business model provides stability to our business, operating results and overall financial position, the broader implications of these macroeconomic or geopolitical events, particularly in the long term, remain uncertain. Further, the negative impact of these events or disruptions may be deferred due to our business model.
See Part I, Item 1A, Risk Factors of this Annual Report on Form 10-K for further discussion of the impact of global economic and geopolitical uncertainty on our business, operations and financial condition.
Developments in Export Control Regulations
On October 7, 2022, the Bureau of Industry and Security (BIS) of the U.S. Department of Commerce published changes to U.S. export control regulations (U.S. Export Regulations), including new restrictions on Chinese entities' ability to obtain advanced computing chips, develop and maintain supercomputers, and manufacture advanced semiconductors. Further, on October 14, 2022, a new rule went into effect imposing U.S. export controls on additional technologies, including electronic computer-aided design software specially designed for the development of ICs with Gate-All-Around Field-Effect Transistor structures. On October 17, 2023, the Department of Commerce, Bureau of Industry and Security, published clarifications of and other adjustments to the regulations promulgated on October 7, 2022, pertaining, among other things, to China’s access to certain semiconductor and advanced computing technology. Based on our current understanding, we believe these regulations will not have a material impact on our business. We anticipate additional changes to U.S. Export Regulations in the future, but we cannot forecast the scope or timing of such changes. We will continue to monitor such developments, including potential additional trade restrictions, and other regulatory or policy changes by the U.S. and foreign governments.
For more on risks related to government export and import restrictions such as the U.S. government’s Entity List and other U.S. Export Regulations, see Part I, Item 1A, Risk Factors, “Industry Risks – We are subject to
governmental export and import requirements that could subject us to liability and restrict our ability to sell our products and services, which could impair our ability to compete in international markets.”
Business Segments
Effective in the first quarter of fiscal 2023, we realigned our organizational structure to evaluate the results of our Design IP business separately. Our Chief Operating Decision Maker (CODM), our Chief Executive Officer, now regularly reviews disaggregated segment information, assesses performance against our key growth strategies and allocates resources based on this new organizational structure. As a result, effective in the first quarter of fiscal 2023, we changed our reportable segments from two reportable segments to the following three reportable segments: (1) Design Automation, which includes our advanced silicon design, verification products and services, system integration products and services, digital, custom and FPGA IC design software, verification software and hardware products, manufacturing software products and other; (2) Design IP, which includes our Design IP products; and (3) Software Integrity, which includes solutions that test software code for security vulnerabilities and quality defects, as well as professional and managed services. As such, prior period reportable segment results and related disclosures have been reclassified to reflect our current reportable segments.
As a result of the change in reporting structure, financial information provided to and used by the CODM to assist in making operational decisions, allocating resources and assessing performance reflects consolidated financial information as well as revenue, adjusted operating income, and adjusted operating margin for the Design Automation, Design IP, and Software Integrity segments, accompanied by disaggregated information relating to revenues by geographic region.
Design Automation. This segment includes our advanced silicon design, verification products and services and system integration products. This segment also includes digital, custom and FPGA IC design software, verification software and hardware products, system integration products and services, and manufacturing software products. Designers use these products to automate the highly complex IC design process and to reduce defects that could lead to expensive design or manufacturing re-spins or suboptimal end products.
Design IP. This segment includes our Design IP products that serve companies primarily in the semiconductor and electronics industries. We are a leading provider of high-quality, silicon-proven IP solutions for system-on-chips (SoCs). This includes IP that has been optimized to address specific application requirements for the mobile, automotive, digital home, internet of things and cloud computing markets, enabling designers to quickly develop SoCs in these areas.
Software Integrity. This segment includes a broad portfolio of products and services to intelligently address software risks across the customer’s portfolio and at all stages of the application lifecycle. The testing tools, services, and programs enable our customers to manage open source license compliance and detect, prioritize, and remediate security vulnerabilities and defects across their entire software development lifecycle. Our offerings include security and quality testing products, managed services, programs and professional services, and training.
Fiscal Year End
Our fiscal year ends on the Saturday nearest to October 31 and consists of 52 weeks, with the exception that approximately every five years, we have a 53-week year. When a 53-week year occurs, we include the additional week in the first quarter to realign fiscal quarters with calendar quarters. Fiscal 2023, 2022 and 2021 were 52-week years ending on October 28, 2023, October 29, 2022, and October 30, 2021, respectively. Fiscal 2024 will be a 53-week year.
For presentation purposes, this Annual Report on Form 10-K refers to the closest calendar month end.
Critical Accounting Estimates
Our consolidated financial statements have been prepared in accordance with U.S. GAAP. In preparing these financial statements, we make assumptions, judgments and estimates that can affect the reported amounts of assets, liabilities, revenues and expenses, and net income. On an ongoing basis, we evaluate our estimates based on historical experience and various other assumptions that we believe are reasonable under the circumstances. Our actual results may differ from these estimates. See Note 2. Summary of Significant Accounting Policies and Basis of Presentation of the Notes to Consolidated Financial Statements for further information on our significant accounting policies.
The accounting policies that most frequently require us to make assumptions, judgments and estimates, and therefore are critical to understanding our results of operations, are:
•Revenue recognition; and
•Business combinations.
Revenue Recognition
Our contracts with customers often include promises to transfer multiple products and services to a customer. Arrangements with customers can involve multiple products and various license rights. Customers can negotiate for a broad portfolio of solutions, and favorable terms along with future purchase options to manage their overall costs. Analysis of the terms and conditions in these contracts and their effect on revenue recognition may require significant judgment.
We have concluded that our EDA software licenses in Technology Subscription License (TSL) contracts are not distinct from our obligation to provide unspecified software updates to the licensed software throughout the license term, because those promises represent inputs to a single, combined performance obligation. Where unspecified additional software product rights are part of the contract with the customer, those rights are accounted for as part of the single performance obligation that includes the licenses, updates, and technical support, because such rights are provided during the same period of time and have the same time-based pattern of transfer to the customer.
For our IP licensing arrangements, we have concluded that the licenses and support services are distinct from each other, and therefore treated as separate performance obligations. Revenues from IP licenses are recognized at a point in time upon transfer of control of the IP license, and support services are recognized over the support period as a stand ready obligation to the customer.
We are required to estimate total consideration expected to be received from contracts with customers. In some circumstances, the consideration expected to be received is variable based on the specific terms of the contract or based on our expectations of the term of the contract. Generally, we have not experienced significant returns or refunds to customers. These estimates require significant judgment and the change in these estimates could have an effect on our results of operations during the periods involved.
Business Combinations
We allocate the purchase price of acquired companies to the tangible and intangible assets acquired and liabilities assumed based upon their estimated fair values on the acquisition date with the exception of contract assets and contract liabilities (deferred revenue) which are recognized and measured on the acquisition date in accordance with our "Revenue Recognition" policy in Note 2. Summary of Significant Accounting Policies and Basis of Presentation of the Notes to Consolidated Financial Statements in this Annual Report on Form 10-K, as if we had originated the contracts. The excess of the purchase price over the fair values of these net tangible and intangible assets acquired is recorded as goodwill.
Accounting for business combinations requires management to make significant estimates and assumptions including our estimates for intangible assets. Although we believe the assumptions and estimates we have made are reasonable, they are based in part on historical experience, market conditions and information obtained from management of the acquired companies and are inherently uncertain. Examples of critical estimates in valuing certain of the intangible assets we have acquired or may acquire in the future include, but are not limited to:
•future expected cash flows from software license sales, subscriptions, support agreements, consulting contracts and acquired developed technologies and patents;
•historical and expected customer attrition rates and anticipated growth in revenue from acquired customers;
•estimated obsolescence rates used in valuing technology related intangible assets;
•the expected use of the acquired assets; and
•discount rates used to discount expected future cash flows to present value, which are typically derived from a weighted-average cost of capital analysis and adjusted to reflect inherent risks.
The fair value of the definite-lived intangibles was determined using variations of the income approach.
For acquisitions completed in fiscal 2023, the fair value for acquired existing technology was determined by applying the relief from royalty method under the income approach. The relief from royalty method applies a royalty rate to projected income to quantify the benefit of owning the intangible asset rather than paying a royalty for use of the asset. The economic useful life was determined based on historical technology obsolescence patterns and prospective technology developments. We assumed royalty rates ranging from 40% to 55%. The present value of operating cash flows from the existing technology was determined using discount rates ranging from approximately 10% to 20%.
Customer relationships represent the fair value of the existing relationships with the acquired company’s customers. Their fair value was determined using the multi-period excess earnings method under the income approach, which involves isolating the net earnings attributable to the asset being measured based on the present value of the incremental after-tax cash flows (excess earnings) attributable solely to the asset over its remaining useful life. The economic useful life was determined based on historical customer turnover rates. Projected income from existing customer relationships considered customer retention rates ranging from 85% to 100%. The present value of operating cash flows from existing customers was determined using discount rates ranging from approximately 10% to 20%.
We believe that our estimates and assumptions related to the fair value of acquired intangible assets are reasonable, but significant judgment is involved.
Results of Operations
The discussion of our consolidated results of operations includes year-over-year comparisons of fiscal 2023 changes compared to fiscal 2022. We have also included a comparison of segment results for fiscal 2022 and 2021 due to the change in reportable segments in the beginning of fiscal 2023. For a discussion of other fiscal 2022 changes compared to fiscal 2021, see the discussion in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended October 31, 2022, filed on December 12, 2022.
Revenue
Our revenues are generated from three business segments: the Design Automation segment, the Design IP segment and the Software Integrity segment. See Note 17. Segment Disclosure of the Notes to Consolidated Financial Statements for more information about our reportable segments and revenue by geographic regions.
Further disaggregation of the revenues into various products and services within these three segments is summarized as follows:
Design Automation Segment
•EDA solutions include digital, custom and FPGA IC design software, verification software and hardware products, system integration products and services, and obligations to provide unspecified updates and support services. EDA products and services are typically sold through TSL arrangements that grant customers the right to access and use all of the licensed products at the outset of an arrangement; software updates are generally made available throughout the entire term of the arrangement. The duration of our TSL contracts is generally three years, though it may vary for specific arrangements. We have concluded that the software licenses in TSL contracts are not distinct from the obligation to provide unspecified software updates to the licensed software throughout the license term, because the multiple software licenses and support represent inputs to a single, combined offering, and timely, relevant software updates are integral to maintaining the utility of the software licenses. We recognize revenue for the combined performance obligation under TSL contracts ratably over the term of the license.
•In the case of arrangements involving the sale of hardware products, we generally have two performance obligations. The first performance obligation is to transfer the hardware product, which includes software integral to the functionality of the hardware product. The second performance obligation is to provide maintenance on the hardware and its embedded software, which includes rights to technical support, hardware repairs and software updates that are all provided over the same term and have the same time-based pattern of transfer to the customer. The portion of the transaction price allocated to the hardware product is generally recognized as revenue at the time of shipment because
the customer obtains control of the product at that point in time. We have concluded that control generally transfers at that point in time because the customer has the ability to direct the use of the asset and an obligation to pay for the hardware. The portion of the transaction price allocated to the maintenance obligation is recognized as revenue ratably over the maintenance term.
•Revenue from Professional Service contracts is recognized over time, generally using costs incurred or hours expended to measure progress. We have a history of reasonably estimating project status and the costs necessary to complete projects. A number of internal and external factors can affect these estimates, including labor rates, utilization and efficiency variances and specification and testing requirement changes.
Design IP Segment
•Design IP includes our Synopsys IP portfolio. These arrangements generally have two performance obligations which consist of transferring of the licensed IP and providing related support, which includes rights to technical support and software updates that are provided over the support term and are transferred to the customer over time. Revenue allocated to the IP licenses is recognized at a point in time upon the later of the delivery date or the beginning of the license period, and revenue allocated to support is recognized over the support term. Royalties are recognized as revenue in the quarter in which the applicable customer sells its products that incorporate our IP. Payments for IP contracts are generally received upon delivery of the IP. Revenue related to the customization of certain IP is recognized over time, generally using costs incurred or hours expended to measure progress.
Software Integrity Segment
•We sell Software Integrity products in arrangements that provide customers the right to software licenses, maintenance updates and technical support. Over the term of these arrangements, the customer expects us to provide integral maintenance updates to the software licenses, which help customers protect their own software from new critical quality defects and potential security vulnerabilities. The licenses and maintenance updates serve together to fulfill our commitment to the customer as both work together to provide functionality to the customer and represent a combined performance obligation. We recognize revenue for the combined performance obligation over the term of the arrangement.
Our customer arrangements can involve multiple products and various license rights, and our customers negotiate with us over many aspects of these arrangements. For example, they generally request a broader portfolio of solutions, support and services and seek more favorable terms such as expanded license usage, future purchase rights and other unique rights at an overall lower total cost. No single factor typically drives our customers’ buying decisions, and we compete on all fronts to serve customers in highly competitive markets. Customers generally negotiate the total value of the arrangement rather than just unit pricing or volumes.
Total Revenue
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended October 31, | | $ Change | | % Change | | $ Change | | % Change |
| 2023 | | 2022 | | 2021 | | 2023 vs. 2022 | | 2022 vs. 2021 |
| (dollars in millions) |
Design Automation | $ | 3,775.3 | | | $ | 3,300.2 | | | $ | 2,754.7 | | | $ | 475.1 | | | 14 | % | | $ | 545.5 | | | 20 | % |
Design IP | 1,542.7 | | | 1,315.5 | | | 1,055.7 | | | 227.2 | | | 17 | % | | 259.8 | | | 25 | % |
Software Integrity | 524.6 | | | 465.8 | | | 393.8 | | | 58.8 | | | 13 | % | | 72.0 | | | 18 | % |
Total | $ | 5,842.6 | | | $ | 5,081.5 | | | $ | 4,204.2 | | | $ | 761.1 | | | 15 | % | | $ | 877.3 | | | 21 | % |
Our revenues are subject to fluctuations, primarily due to customer requirements including the timing and value of contract renewals. For example, we experience fluctuations in our revenues due to factors such as the timing of IP product sales, Flexible Spending Account (FSA) drawdowns, royalties, and hardware products sales. As revenues from IP products sales and hardware products sales are recognized upfront, customer demand and timing requirements for such IP products and hardware products could result in increased variability of our total revenues.
Contracted but unsatisfied or partially unsatisfied performance obligations (backlog) as of October 31, 2023 were approximately $8.6 billion, which includes $1.4 billion in non-cancellable FSA commitments from customers where actual product selection and quantities of specific products or services are to be determined by customers at a later date. We have elected to exclude future sales-based royalty payments from the remaining performance obligations.
Approximately 40% of the backlog as of October 31, 2023, excluding non-cancellable FSA, is expected to be recognized as revenue over the next 12 months. The majority of the remaining backlog is expected to be recognized in the following three years. The backlog was approximately $7.1 billion as of October 31, 2022, which included $1.1 billion in non-cancellable FSA commitments from customers.
The amount and composition of unsatisfied performance obligations will fluctuate period to period. We do not believe the amount. of unsatisfied performance obligations is indicative of future sales or revenue, or that such obligations at the end of any given period correlates with actual sales performance of a particular geography or particular products and services. For more information regarding our revenue as of October 31, 2023, including our contract balances as of such date, see Note 3. Revenue of the Notes to Consolidated Financial Statements.
For fiscal 2023 compared to fiscal 2022, revenues increased due to the continued organic growth of our business in all product groups and geographies.
For a discussion of revenue by geographic areas, see Note 17. Segment Disclosure of the Notes to Consolidated Financial Statements.
Time-Based Products Revenue
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended October 31, | | | | | | | | |
| 2023 | | 2022 | | | | $ Change | | % Change | | |
| (dollars in millions) |
Time-based products revenue | $ | 3,383.6 | | | $ | 2,993.8 | | | | | $ | 389.8 | | | 13 | % | | | | |
Percentage of total revenue | 58 | % | | 59 | % | | | | | | | | | | |
The increase in time-based products revenue for fiscal 2023 compared to fiscal 2022 was primarily attributable to an increase in TSL license revenue from arrangements booked in prior periods.
Upfront Products Revenue
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended October 31, | | | | | | | | |
| 2023 | | 2022 | | | | $ Change | | % Change | | |
| (dollars in millions) |
Upfront products revenue | $ | 1,429.3 | | | $ | 1,226.7 | | | | | $ | 202.6 | | | 17 | % | | | | |
Percentage of total revenue | 24 | % | | 24 | % | | | | | | | | | | |
Changes in upfront products revenue are generally attributable to normal fluctuations in the extent and timing of customer requirements, which can drive the amount of upfront orders and revenue in any particular period.
The increase in upfront products revenue for fiscal 2023 compared to fiscal 2022 was primarily due to an increase in the sale of IP products and hardware products driven by higher demand from customers.
Upfront products revenue as a percentage of total revenue will likely fluctuate based on the timing of IP and hardware product sales. Such fluctuations will continue to be impacted by the timing of shipments and FSA drawdowns due to customer requirements.
Maintenance and Service Revenue
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended October 31, | | | | | | | | |
| 2023 | | 2022 | | | | $ Change | | % Change | | |
| (dollars in millions) |
Maintenance revenue | $ | 361.7 | | | $ | 293.3 | | | | | $ | 68.4 | | | 23 | % | | | | |
Professional service and other revenue | 668.0 | | | 567.7 | | | | | 100.3 | | | 18 | % | | | | |
Total | $ | 1,029.7 | | | $ | 861.0 | | | | | $ | 168.7 | | | 20 | % | | | | |
Percentage of total revenue | 18 | % | | 17 | % | | | | | | | | | | |
The increase in maintenance revenue for fiscal 2023 compared to fiscal 2022 was primarily due to an increase in the volume of hardware arrangements that include maintenance.
The increase in professional services and other revenue for fiscal 2023 compared to fiscal 2022 was primarily due to the timing of IP customization projects.
Cost of Revenue
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended October 31, | | | | | | | | |
| 2023 | | 2022 | | | | $ Change | | % Change | | |
| (dollars in millions) |
Cost of products revenue | $ | 763.5 | | | $ | 653.8 | | | | | $ | 109.7 | | | 17 | % | | | | |
Cost of maintenance and service revenue | 383.8 | | | 343.0 | | | | | 40.8 | | | 12 | % | | | | |
Amortization of intangible assets | 74.9 | | | 66.9 | | | | | 8.0 | | | 12 | % | | | | |
Total | $ | 1,222.2 | | | $ | 1,063.7 | | | | | $ | 158.5 | | | 15 | % | | | | |
Percentage of total revenue | 21 | % | | 21 | % | | | | | | | | | | |
We divide cost of revenue into three categories: cost of products revenue, cost of maintenance and service revenue, and amortization of intangible assets.
Cost of products revenue. Cost of products revenue includes costs related to products sold and software licensed, hardware-related costs including inventory provisions, allocated operating costs related to product support and distribution, royalties paid to third-party vendors, and the amortization of capitalized software development costs.
Cost of maintenance and service revenue. Cost of maintenance and service revenue includes costs to deliver our maintenance services, such as hotline and on-site support, production services and documentation of maintenance updates.
Amortization of intangible assets. Amortization of intangible assets, included in cost of revenue, consists of the amortization of core/developed technology and certain contract rights intangible assets related to acquisitions.
The increase in cost of revenue for fiscal 2023 compared to fiscal 2022 was primarily due to increases of $62.2 million in employee-related costs as a result of headcount increases from hiring, $53.5 million in hardware-related costs including inventory provisions, $13.1 million in facility costs, $8.0 million in amortization of technology-related intangible assets, $6.7 million in costs to fulfill IP consulting arrangements, and $6.1 million in the change in fair value of our executive deferred compensation plan assets.
Operating Expenses
Research and Development
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended October 31, | | | | | | | | |
| 2023 | | 2022 | | | | $ Change | | % Change | | |
| (dollars in millions) |
Research and development expenses | $ | 1,946.8 | | | $ | 1,680.4 | | | | | $ | 266.4 | | | 16 | % | | | | |
Percentage of total revenue | 33 | % | | 33 | % | | | | | | | | | | |
The increase in research and development expenses for fiscal 2023 compared to fiscal 2022 was primarily due to higher employee-related costs of $139.2 million as a result of headcount increases as we continue to expand and enhance our product portfolio, increases of $57.4 million in the change in fair value of our executive deferred compensation plan assets, $31.0 million in facility costs, and $20.9 million in consultant and contractor costs.
Sales and Marketing
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended October 31, | | | | | | | | |
| 2023 | | 2022 | | | | $ Change | | % Change | | |
| (dollars in millions) |
Sales and marketing expenses | $ | 889.0 | | | $ | 779.8 | | | | | $ | 109.2 | | | 14 | % | | | | |
Percentage of total revenue | 15 | % | | 15 | % | | | | | | | | | | |
The increase in sales and marketing expenses for fiscal 2023 compared to fiscal 2022 was primarily due to increases of $62.9 million in employee-related costs due to headcount increases and higher sales commissions, $13.4 million in the change in fair value of our executive deferred compensation plan assets, $12.0 million in travel and marketing costs due to an increased number of in-person meetings and events, and $8.5 million in facility costs.
General and Administrative
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended October 31, | | | | | | | | |
| 2023 | | 2022 | | | | $ Change | | % Change | | |
| (dollars in millions) |
General and administrative expenses | $ | 410.3 | | | $ | 353.8 | | | | | $ | 56.5 | | | 16 | % | | | | |
Percentage of total revenue | 7 | % | | 7 | % | | | | | | | | | | |
The increase in general and administrative expenses for fiscal 2023 compared to fiscal 2022 was primarily due to increases of $23.4 million in personnel-related costs due to headcount increases from hiring, $16.4 million in maintenance and depreciation expenses, $12.9 million in the change in fair value of our executive deferred compensation plan assets, and $7.4 million in legal, consulting and other professional fees. These increases were partially offset by bad debt recoveries of $15.9 million in the second quarter of fiscal 2022.
Change in Fair Value of Deferred Compensation
The income or loss arising from the change in fair value of our non-qualified deferred compensation plan obligation is recorded in cost of sales and each functional operating expense, with the offsetting change in the fair value of the related assets recorded in other income (expense), net. There is no impact on our net income from the fair value changes in our deferred compensation plan obligation and related assets.
Amortization of Intangible Assets
Amortization of intangible assets included in operating expenses consists of the amortization of trademarks, trade names, and customer relationships intangible assets related to acquisitions.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended October 31, | | | | | | | | |
| 2023 | | 2022 | | | | $ Change | | % Change | | |
| (dollars in millions) |
Amortization of intangible assets | $ | 28.0 | | | $ | 29.8 | | | | | $ | (1.8) | | | (6) | % | | | | |
Percentage of total revenue | — | % | | 1 | % | | | | | | | | | | |
The decrease in amortization of intangible assets for fiscal 2023 compared to fiscal 2022 was primarily due to certain intangible assets becoming fully amortized in fiscal 2023, partially offset by amortization expense related to intangible assets acquired during fiscal 2023.
Restructuring Charges
In the first quarter of fiscal 2023, we initiated a restructuring plan for involuntary employee terminations as part of a business reorganization (the 2023 Plan). The 2023 Plan was substantially completed in the third quarter of fiscal 2023, and total charges under the 2023 Plan were $77.0 million, consisting primarily of severance costs and facility exit costs.
The following is a summary of our restructuring liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | |
Fiscal Year | Balance at Beginning of Period | | Costs Incurred | | Cash Payments | | | | Balance at End of Period |
| (dollars in millions) |
2023 | $ | — | | | $ | 77.0 | | | $ | (68.3) | | | | | $ | 8.7 | |
2022 | $ | 14.2 | | | $ | 12.1 | | | $ | (26.3) | | | | | $ | — | |
2021 | $ | 1.3 | | | $ | 33.4 | | | $ | (20.5) | | | | | $ | 14.2 | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
See Note 18. Restructuring Charges of the Notes to Consolidated Financial Statements for additional information.
Other Income (Expense), Net
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended October 31, | | | | | | | | |
| 2023 | | 2022 | | | | $ Change | | % Change | | |
| (dollars in millions) |
Interest income | $ | 36.7 | | | $ | 8.5 | | | | | $ | 28.2 | | | 332 | % | | | | |
Interest expense | (1.2) | | | (1.7) | | | | | 0.5 | | | (29) | % | | | | |
Gains (losses) on assets related to executive deferred compensation plan | 20.5 | | | (68.8) | | | | | 89.3 | | | (130) | % | | | | |
Foreign currency exchange gains (losses) | (1.5) | | | 4.7 | | | | | (6.2) | | | (132) | % | | | | |
Other, net | (22.0) | | | 10.8 | | | | | (32.8) | | | (304) | % | | | | |
Total | $ | 32.5 | | | $ | (46.5) | | | | | $ | 79.0 | | | (170) | % | | | | |
The increase in other income (expense) for fiscal 2023 as compared to fiscal 2022 was primarily due to the increase in the fair value of our executive deferred compensation plan assets.
Segment Operating Results
We do not allocate certain operating expenses managed at a consolidated level to our reportable segments. These unallocated expenses consist primarily of stock-based compensation expense, amortization of intangible assets, changes in the fair value of deferred compensation plan, restructuring charges, and certain other operating expenses. See Note 17. Segment Disclosure of the Notes to Consolidated Financial Statements for more information.
Design Automation Segment
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended October 31, | | $ Change | | % Change | | $ Change | | % Change |
| 2023 | | 2022 | | 2021 | | 2023 vs. 2022 | | 2022 vs. 2021 |
| (dollars in millions) |
Adjusted operating income | $ | 1,439.7 | | | $ | 1,206.6 | | | $ | 924.6 | | | $ | 233.1 | | | 19 | % | | $ | 282.0 | | | 30 | % |
Adjusted operating margin | 38 | % | | 37 | % | | 34 | % | | 1 | % | | 3 | % | | 3 | % | | 9 | % |
The increase in adjusted operating income for both fiscal 2023 compared to fiscal 2022 and fiscal 2022 compared to fiscal 2021 was primarily due to an increase in revenue from arrangements booked in prior periods.
Design IP Segment
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended October 31, | | $ Change | | % Change | | $ Change | | % Change |
| 2023 | | 2022 | | 2021 | | 2023 vs. 2022 | | 2022 vs. 2021 |
| (dollars in millions) |
Adjusted operating income | $ | 532.1 | | | $ | 421.5 | | | $ | 318.5 | | | $ | 110.6 | | | 26 | % | | $ | 103.0 | | | 32 | % |
Adjusted operating margin | 34 | % | | 32 | % | | 30 | % | | 2 | % | | 6 | % | | 2 | % | | 7 | % |
The increase in adjusted operating income for both fiscal 2023 compared to fiscal 2022 and fiscal 2022 compared to fiscal 2021 was primarily due to an increase in the revenue of IP products driven by timing of customer demands.
Software Integrity Segment
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended October 31, | | $ Change | | % Change | | $ Change | | % Change |
| 2023 | | 2022 | | 2021 | | 2023 vs. 2022 | | 2022 vs. 2021 |
| (dollars in millions) |
Adjusted operating income | $ | 76.3 | | | $ | 47.0 | | | $ | 38.3 | | | $ | 29.3 | | | 62 | % | | $ | 8.7 | | | 23 | % |
Adjusted operating margin | 15 | % | | 10 | % | | 10 | % | | 5 | % | | 50 | % | | — | % | | — | % |
The increase in adjusted operating income for both fiscal 2023 compared to fiscal 2022 and fiscal 2022 compared to fiscal 2021 was primarily due to an increase in revenue from arrangements booked in prior periods.
Income Taxes
Our effective tax rate for fiscal 2023 is 6.4%, which included a tax benefit of $65.9 million of U.S. federal research tax credit, a foreign derived intangible income (FDII) deduction of $82.4 million, and excess tax benefits from stock-based compensation of $84.5 million.
Our effective tax rate for fiscal 2022 was 12.3%, which included a tax benefit of $61.5 million of U.S. federal research tax credit, a FDII deduction of $38.9 million, and excess tax benefits from stock-based compensation of $88.8 million.
The Tax Act provides an exemption from federal income taxes for distributions from foreign subsidiaries made after December 31, 2017 that were not subject to the one-time transition tax. We have provided for foreign withholding taxes on undistributed earnings of certain of our foreign subsidiaries to the extent such earnings are no longer considered to be indefinitely reinvested in the operations of those subsidiaries.
In 2017, the Hungarian Tax Authority (the HTA) assessed withholding taxes of approximately $25.0 million and interest and penalties of $11.0 million, against our Hungary subsidiary (Synopsys Hungary). Synopsys Hungary contested the assessment with the Hungarian Administrative Court (Administrative Court). In 2019, as required under Hungarian law, Synopsys Hungary paid the assessment and recorded a tax expense due to an unrecognized tax benefit of $17.4 million, which is net of estimated U.S. foreign tax credits. During 2021 and 2022 a series of appeals, hearings and re-hearings occurred at the Administrative Court and Hungarian Supreme Court. Hearings with the Administrative Court were held on June 30, 2022, September 22, 2022 and April 25, 2023. The Administrative Court issued its written decision in favor of Synopsys Hungary on May 17, 2023, and subsequently refunded Synopsys Hungary the tax, penalty and interest paid in fiscal 2018, as well as additional interest all totaling $39.1 million (including the effect of currency movement). The refunded tax, penalty and interest was recognized as an income tax benefit. The HTA had until July 14, 2023, to file an appeal with the Hungarian Supreme Court and the HTA did not appeal. This concludes the litigation. During the third quarter of fiscal 2023, Synopsys released its unrecognized tax benefit and offsetting U.S. foreign tax credits, resulting in a net benefit of $23.8 million.
See Note 15. Income Taxes of the Notes to Consolidated Financial Statements for further discussion of the provision for income taxes, the impacts related to the Tax Act, and the Hungarian audit.
Liquidity and Capital Resources
Our principal sources of liquidity are funds generated from our business operations and funds that may be drawn down under our revolving credit and term loan facilities.
As of October 31, 2023, we held $1.6 billion in cash, cash equivalents and short-term investments. We also held $2.3 million in restricted cash primarily associated with deposits for office leases and employee loan programs. Our cash equivalents consisted primarily of taxable money market mutual funds, time deposits and highly liquid investments with maturities of three months or less. Our short-term investments include U.S. government and municipal obligations, investment-grade available-for-sale debt and asset backed securities with an overall weighted-average credit rating of approximately AA.
As of October 31, 2023, approximately $753.7 million of our cash and cash equivalents were domiciled in various foreign jurisdictions. We have provided for foreign withholding taxes on the undistributed earnings of certain of our foreign subsidiaries to the extent such earnings are no longer considered to be indefinitely reinvested in the operations of those subsidiaries.
We believe that our existing cash, cash equivalents and short-term investments and sources of liquidity will be sufficient to satisfy our cash requirements and capital return program over the next 12 months and beyond. We are currently not aware of any trends or demands, commitments, events or uncertainties that will result in, or that are reasonably likely to result in, our liquidity increasing or decreasing in any material way that will impact our capital needs during or beyond the next 12 months. Our future cash requirements will depend on many factors, including our rate of revenue growth, the expansion of our sales and marketing activities, and the timing and extent of our spending to support our research and development efforts. We also may invest in or acquire businesses, applications or technologies, or may further expand our board-authorized stock repurchase program, which may require the use of significant cash resources and/or additional financing.
Effective fiscal 2023, our research and development expenditures are required to be capitalized and amortized under the Tax Act instead of being deducted when incurred for US tax purposes. As a result of the IRS tax relief for the California winter storms, the due date for our fiscal 2023 federal tax payment was November 16, 2023 and as such, we have deferred our fiscal 2023 federal cash tax payments until the first quarter of fiscal 2024. This results in
a significant increase to our cash outflows beginning in fiscal 2024. See Note 15. Income Taxes of the Notes to Consolidated Financial Statements for further discussion.
Cash Flows
| | | | | | | | | | | | | | | | | | | | | |
| Year Ended October 31, | | | | |
| 2023 | | 2022 | | | | $ Change | | |
| (dollars in millions) |
Cash provided by operating activities | $ | 1,703.3 | | | $ | 1,738.9 | | | | | $ | (35.6) | | | |
Cash used in investing activities | $ | (482.1) | | | $ | (572.6) | | | | | $ | 90.5 | | | |
Cash used in financing activities | $ | (1,196.9) | | | $ | (1,116.3) | | | | | $ | (80.6) | | | |
Cash Provided by Operating Activities
We expect cash from our operating activities to fluctuate as a result of a number of factors, including the timing of our billings and collections, our operating results, and the timing and amount of tax and other liability payments. Cash provided by our operations is dependent primarily upon the payment terms of our license agreements. We generally receive cash from upfront arrangements much sooner than from time-based products revenue, in which the license fee is typically paid either quarterly or annually over the term of the license.
The decrease in cash provided by operating activities was primarily attributable to the timing of customer billings and higher disbursements for operations, partially offset by higher net income and higher accounts receivable collection.
Cash Used in Investing Activities
The decrease in cash used in investing activities was primarily due to lower cash paid for acquisitions of $124.7 million and higher proceeds from the sales and maturities of investments of $44.6 million, partially offset by higher purchases of property and equipment of $53.0 million and higher purchases of investments of $27.3 million.
Cash Used in Financing Activities
The increase in cash used in financing activities was primarily due to higher stock repurchases of $105.7 million, higher taxes paid for net share settlements of $67.4 million partially offset by lower debt repayments of $74.2 million and higher proceeds from issuance of common stock of $15.0 million.
Credit and Term Loan Facilities
On December 14, 2022, we entered into a Fifth Extension and Amendment Agreement (the Fifth Amendment), which amended and restated our previous credit agreement, dated as of January 22, 2021 (as amended and restated, the Credit Agreement).
The Fifth Amendment increased the existing senior unsecured revolving credit facility (the Revolver) from $650.0 million to $850.0 million and extended the maturity date from January 22, 2024 to December 14, 2027, which could be further extended at our option. The Credit Agreement also provides an uncommitted incremental revolving loan facility of up to $150.0 million in the aggregate principal amount. The Credit Agreement contains a financial covenant requiring us to maintain a maximum consolidated leverage ratio, as well as other non-financial covenants. There was no outstanding balance under the Revolver as of October 31, 2023.
In July 2018, we entered into a 12-year 220.0 million Renminbi (approximately $33.0 million) credit agreement with a lender in China to support our facilities expansion. Borrowings bear interest at a floating rate based on the 5-year Loan Prime Rate plus 0.74%. As of October 31, 2023, we had a $18.1 million outstanding balance under the agreement. See Note 7. Financial Assets and Liabilities of the Notes to Consolidated Financial Statements for further discussion.
Stock Repurchase Program
In fiscal 2022, our Board of Directors approved a stock repurchase program with authorization to purchase up to $1.5 billion of our common stock. During the fiscal year 2023, we repurchased 3.0 million shares of common stock at an average price of $387.92 per share for an aggregate purchase price of $1.2 billion. As of October 31, 2023, $194.3 million remained available for future stock repurchases. The pace of our repurchase activity will depend on factors such as our working capital needs, our cash requirements for acquisitions, our debt repayment obligations, our stock price, and economic and market conditions.
The IR Act was enacted in the United States on August 16, 2022. The IR Act imposes a 1% excise tax on the fair market value of stock repurchases made by covered corporations after December 31, 2022. The total taxable value of shares repurchased is reduced by the fair market value of any newly issued shares during the taxable year. As of October 31, 2023, this does not have any impact on our consolidated financial statements. Risks related to the IR Act are described in Part I, Item 1A, Risk Factors.
Material Cash Requirements
Our material cash requirements include the following contractual and other obligations.
Leases
We have operating lease arrangements for office space, data center, equipment and other corporate assets. As of October 31, 2023, we had lease payment obligations, net of immaterial sublease income, of $614.8 million, with $84.6 million payable within 12 months.
Purchase Obligations
Purchase obligations represent an estimate of all open purchase orders and contractual obligations in the ordinary course of business for which we have not received the goods or services. As of October 31, 2023, we had $604.3 million of purchase obligations, with $464.2 million payable within 12 months. Although open purchase orders are considered enforceable and legally binding, the terms may allow us the option to cancel, reschedule and adjust our requirements based on our business needs prior to the delivery of goods or performance of services.
Term Loan
Refer to "Credit and Term Loan Facilities” under Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations included in this Annual Report on Form 10-K for more information.
Long Term Accrued Income Taxes
As of October 31, 2023, we had $22.0 million of long-term accrued income taxes which represent uncertain tax benefits. Currently, a reasonably reliable estimate of timing of payments related to uncertain tax benefits in individual years beyond fiscal 2023 cannot be made due to uncertainties in timing of the commencement and settlement of potential tax audits.
| | |
Item 8. Financial Statements and Supplementary Data |
Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors
Synopsys, Inc.:
Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting
We have audited the accompanying consolidated balance sheets of Synopsys, Inc. and subsidiaries (the Company) as of October 28, 2023 and October 29, 2022, the related consolidated statements of income, comprehensive income, stockholders’ equity, and cash flows for each of the fiscal years in the three-year period ended October 28, 2023, and the related notes (collectively, the consolidated financial statements). We also have audited the Company’s internal control over financial reporting as of October 28, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of October 28, 2023 and October 29, 2022, and the results of its operations and its cash flows for each of the fiscal years in the three-year period ended October 28, 2023, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of October 28, 2023 based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
Basis for Opinions
The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Evaluation of the Company’s analysis of terms and conditions in software and intellectual property license contracts with customers
As discussed in Notes 2 and 3 to the consolidated financial statements, the Company generates revenue from the sale of products that include software and intellectual property (IP) licenses, hardware products, maintenance and services. The Company’s contracts with customers often include promises to transfer multiple products and services to a customer. Arrangements with customers can involve hundreds of products and various license rights, and customers negotiate with the Company over many aspects of these arrangements. The Company’s customers often request a broader portfolio of solutions, support and services and seek more favorable terms such as expanded license usage, future purchase rights and other unique rights at an overall lower total cost. The Company recognized total revenue of $5,842.6 million for the year ended October 28, 2023, which included revenue related to software and IP licenses.
We identified the evaluation of the Company’s analysis of terms and conditions in significant software and IP license contracts with customers and their effect on revenue recognition as a critical audit matter. Complex auditor judgment was required to assess the Company’s judgments made in applying revenue recognition requirements to certain terms and conditions.
The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the Company’s revenue recognition process, including the Company’s analysis of terms and conditions in software and IP license contracts with customers and their effect on revenue recognition. We tested certain software and IP license customer contracts by inspecting the underlying customer agreements and evaluating the Company’s assessment of the contractual terms and conditions in accordance with revenue recognition requirements. For a selection of software and IP license contracts with customers entered during the year, we inquired of personnel outside of the accounting function to corroborate our understanding of certain terms and conditions.
/s/ KPMG LLP
We have served as the Company’s auditor since 1992.
Santa Clara, California
December 12, 2023
SYNOPSYS, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except par value amounts)
| | | | | | | | | | | |
| October 31, |
| 2023 | | 2022 |
ASSETS | | | |
Current assets: | | | |
Cash and cash equivalents | $ | 1,438,913 | | | $ | 1,417,608 | |
Short-term investments | 151,639 | | | 147,913 | |
Total cash, cash equivalents and short-term investments | 1,590,552 | | | 1,565,521 | |
Accounts receivable, net | 946,967 | | | 796,091 | |
Inventories | 325,590 | | | 211,927 | |
| | | |
Prepaid and other current assets | 567,515 | | | 439,130 | |
Total current assets | 3,430,624 | | | 3,012,669 | |
Property and equipment, net | 557,261 | | | 483,300 | |
Operating lease right-of-use assets, net | 568,829 | | | 559,090 | |
Goodwill | 4,070,336 | | | 3,842,234 | |
Intangible assets, net | 374,194 | | | 386,446 | |
| | | |
Deferred income taxes | 860,914 | | | 670,653 | |
Other long-term assets | 470,973 | | | 463,695 | |
Total assets | $ | 10,333,131 | | | $ | 9,418,087 | |
LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND STOCKHOLDERS’ EQUITY | | | |
Current liabilities: | | | |
Accounts payable and accrued liabilities | $ | 1,123,761 | | | $ | 809,403 | |
Operating lease liabilities | 85,690 | | | 54,274 | |
| | | |
Deferred revenue | 1,776,000 | | | 1,910,822 | |
| | | |
Total current liabilities | 2,985,451 | | | 2,774,499 | |
Long-term operating lease liabilities | 584,035 | | | 581,273 | |
| | | |
Long-term deferred revenue | 175,128 | | | 154,472 | |
Long-term debt | 18,078 | | | 20,824 | |
Other long-term liabilities | 386,138 | | | 327,829 | |
Total liabilities | 4,148,830 | | | 3,858,897 | |
Redeemable non-controlling interest | 31,043 | | | 38,664 | |
Stockholders’ equity: | | | |
Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding | — | | | — | |
Common stock, $0.01 par value: 400,000 shares authorized; 152,053 and 152,375 shares outstanding, respectively | 1,521 | | | 1,524 | |
Capital in excess of par value | 1,276,152 | | | 1,487,126 | |
Retained earnings | 6,741,699 | | | 5,534,307 | |
Treasury stock, at cost: 5,207 and 4,886 shares, respectively | (1,675,650) | | | (1,272,955) | |
Accumulated other comprehensive income (loss) | (196,414) | | | (234,277) | |
Total Synopsys stockholders’ equity | 6,147,308 | | | 5,515,725 | |
Non-controlling interest | 5,950 | | | 4,801 | |
Total stockholders’ equity | 6,153,258 | | | 5,520,526 | |
Total liabilities, redeemable non-controlling interest and stockholders’ equity | $ | 10,333,131 | | | $ | 9,418,087 | |
See the accompanying Notes to Consolidated Financial Statements.
SYNOPSYS, INC.
CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
Revenue: | | | | | |
Time-based products | $ | 3,383,632 | | | $ | 2,993,786 | | | $ | 2,633,763 | |
Upfront products | 1,429,330 | | | 1,226,728 | | | 861,063 | |
Total products revenue | 4,812,962 | | | 4,220,514 | | | 3,494,826 | |
Maintenance and service | 1,029,657 | | | 861,028 | | | 709,367 | |
Total revenue | 5,842,619 | | | 5,081,542 | | | 4,204,193 | |
Cost of revenue: | | | | | |
Products | 763,494 | | | 653,783 | | | 542,114 | |
Maintenance and service | 383,835 | | | 342,978 | | | 271,202 | |
Amortization of intangible assets | 74,864 | | | 66,936 | | | 48,461 | |
Total cost of revenue | 1,222,193 | | | 1,063,697 | | | 861,777 | |
Gross margin | 4,620,426 | | | 4,017,845 | | | 3,342,416 | |
Operating expenses: | | | | | |
Research and development | 1,946,813 | | | 1,680,379 | | | 1,504,823 | |
Sales and marketing | 889,016 | | | 779,777 | | | 712,491 | |
General and administrative | 410,311 | | | 353,840 | | | 322,988 | |
Amortization of intangible assets | 28,025 | | | 29,754 | | | 33,919 | |
Restructuring charges | 77,002 | | | 12,057 | | | 33,405 | |
Total operating expenses | 3,351,167 | | | 2,855,807 | | | 2,607,626 | |
Operating income | 1,269,259 | | | 1,162,038 | | | 734,790 | |
Other income (expense), net | 32,523 | | | (46,524) | | | 70,724 | |
Income before income taxes | 1,301,782 | | | 1,115,514 | | | 805,514 | |
Provision (benefit) for income taxes | 83,657 | | | 137,078 | | | 49,155 | |
Net income | 1,218,125 | | | 978,436 | | | 756,359 | |
Net income (loss) attributed to non-controlling interest and redeemable non-controlling interest | (11,763) | | | (6,158) | | | (1,157) | |
Net income attributed to Synopsys | $ | 1,229,888 | | | $ | 984,594 | | | $ | 757,516 | |
| | | | | |
Net income per share attributed to Synopsys: | | | | | |
Basic | $ | 8.08 | | | $ | 6.44 | | | $ | 4.96 | |
Diluted | $ | 7.92 | | | $ | 6.29 | | | $ | 4.81 | |
Shares used in computing per share amounts: | | | | | |
Basic | 152,146 | | | 153,002 | | | 152,698 | |
Diluted | 155,195 | | | 156,485 | | | 157,340 | |
See the accompanying Notes to Consolidated Financial Statements.
SYNOPSYS, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
Net income | $ | 1,218,125 | | | $ | 978,436 | | | $ | 756,359 | |
Other comprehensive income (loss): | | | | | |
Change in foreign currency translation adjustment | (13,912) | | | (108,145) | | | 9,415 | |
Change in unrealized gains (losses) on available-for-sale securities, net of tax of $0 for periods presented | 1,513 | | | (2,353) | | | (246) | |
Cash flow hedges: | | | | | |
Deferred gains (losses), net of tax of $(8,940), $28,416, and $(1,736) for fiscal years 2023, 2022 and 2021, respectively | 24,986 | | | (79,069) | | | 9,860 | |
Reclassification adjustment on deferred (gains) losses included in net income, net of tax of $(10,053), $(1,342), and $4,593 for fiscal years 2023, 2022 and 2021, respectively | 25,276 | | | 4,894 | | | (14,559) | |
Other comprehensive income (loss), net of tax effects | 37,863 | | | (184,673) | | | 4,470 | |
Comprehensive income | 1,255,988 | | | 793,763 | | | 760,829 | |
Less: Net income (loss) attributed to non-controlling interest and redeemable non-controlling interest | (11,763) | | | (6,158) | | | (1,157) | |
Comprehensive income attributed to Synopsys | $ | 1,267,751 | | | $ | 799,921 | | | $ | 761,986 | |
See the accompanying Notes to Consolidated Financial Statements.
SYNOPSYS, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(In thousands)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Capital in Excess of Par Value | | Retained Earnings | | Treasury Stock | | Accumulated Other Comprehensive Income (Loss) | | Total Synopsys Stockholders’ Equity | | Non-controlling Interest | | Stockholders' Equity |
| Common Stock | |
| Shares | | Amount | |
Balance at October 31, 2020 | 152,618 | | | $ | 1,528 | | | $ | 1,653,166 | | | $ | 3,795,397 | | | $ | (488,613) | | | $ | (54,074) | | | $ | 4,907,404 | | | $ | 4,963 | | | $ | 4,912,367 | |
Net income | | | | | | | 757,516 | | | | | | | 757,516 | | | (1,157) | | | 756,359 | |
Retained earnings adjustment due to adoption of ASC 326 | | | | | | | (3,200) | | | | | | | (3,200) | | | | | (3,200) | |
Other comprehensive income (loss), net of tax effects | | | | | | | | | | | 4,470 | | | 4,470 | | | | | 4,470 | |
Purchases of treasury stock | (2,780) | | | (28) | | | 28 | | | | | (753,081) | | | | | (753,081) | | | | | (753,081) | |
Equity forward contract, net | | | | | (35,000) | | | | | | | | | (35,000) | | | | | (35,000) | |
Common stock issued, net of shares withheld for employee taxes | 3,224 | | | 31 | | | (387,103) | | | | | 458,828 | | | | | 71,756 | | | | | 71,756 | |
Stock-based compensation | | | | | 345,272 | | | | | | | | | 345,272 | | | | | 345,272 | |
| | | | | | | | | | | | | | | | | |
Balance at October 31, 2021 | 153,062 | | | $ | 1,531 | | | $ | 1,576,363 | | | $ | 4,549,713 | | | $ | (782,866) | | | $ | (49,604) | | | $ | 5,295,137 | | | $ | 3,806 | | | $ | 5,298,943 | |
Net income | | | | | | | 984,594 | | | | | | | 984,594 | | | (1,306) | | | 983,288 | |
| | | | | | | | | | | | | | | | | |
Other comprehensive income (loss), net of tax effects | | | | | | | | | | | (184,673) | | | (184,673) | | | | | (184,673) | |
Purchases of treasury stock | (3,609) | | | (36) | | | 36 | | | | | (1,135,000) | | | | | (1,135,000) | | | | | (1,135,000) | |
Equity forward contract, net | | | | | 35,000 | | | | | | | | | 35,000 | | | | | 35,000 | |
Common stock issued, net of shares withheld for employee taxes | 2,922 | | | 29 | | | (581,001) | | | | | 644,911 | | | | | 63,939 | | | | | 63,939 | |
Stock-based compensation | | | | | 456,728 | | | | | | | | | 456,728 | | | 2,301 | | | 459,029 | |
| | | | | | | | | | | | | | | | | |
Balance at October 31, 2022 | 152,375 | | | $ | 1,524 | | | $ | 1,487,126 | | | $ | 5,534,307 | | | $ | (1,272,955) | | | $ | (234,277) | | | $ | 5,515,725 | | | $ | 4,801 | | | $ | 5,520,526 | |
Net income | | | | | | | 1,229,888 | | | | | | | 1,229,888 | | | (1,761) | | | 1,228,127 | |
Other comprehensive income (loss), net of tax effects | | | | | | | | | | | 37,863 | | | 37,863 | | | | | 37,863 | |
Purchases of treasury stock | (2,992) | | | (30) | | | 30 | | | | | (1,160,724) | | | | | (1,160,724) | | | | | (1,160,724) | |
Equity forward contract, net | | | | | (45,000) | | | | | | | | | (45,000) | | | | | (45,000) | |
Common stock issued, net of shares withheld for employee taxes | 2,670 | | | 27 | | | (725,211) | | | (19,108) | | | 758,029 | | | | | 13,737 | | | | | 13,737 | |
Stock-based compensation | | | | | 558,078 | | | | | | | | | 558,078 | | | 5,214 | | | 563,292 | |
| | | | | | | | | | | | | | | | | |
Adjustments to redeemable non-controlling interest | | | | | | | (3,388) | | | | | | | (3,388) | | | | | (3,388) | |
Recognition of non-controlling interest upon issuance of subsidiary stock | | | | | 1,129 | | | | | | | | | 1,129 | | | (2,304) | | | (1,175) | |
Balance at October 31, 2023 | 152,053 | | | $ | 1,521 | | | $ | 1,276,152 | | | $ | 6,741,699 | | | $ | (1,675,650) | | | $ | (196,414) | | | $ | 6,147,308 | | | $ | 5,950 | | | $ | 6,153,258 | |
See the accompanying Notes to Consolidated Financial Statements.
SYNOPSYS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
Cash flows from operating activities: | | | | | |
Net income | $ | 1,218,125 | | | $ | 978,436 | | | $ | 756,359 | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | | | |
Amortization and depreciation | 247,120 | | | 228,405 | | | 203,676 | |
Reduction of operating lease right-of-use assets | 97,705 | | | 89,541 | | | 86,645 | |
Amortization of capitalized costs to obtain revenue contracts | 82,190 | | | 73,026 | | | 64,698 | |
Stock-based compensation | 563,292 | | | 459,029 | | | 345,272 | |
Allowance for credit losses | 19,932 | | | (3,477) | | | 18,515 | |
| | | | | |
| | | | | |
| | | | | |
Deferred income taxes | (211,045) | | | (36,913) | | | (128,583) | |
Other non-cash | 13,295 | | | 10,188 | | | 15,859 | |
Net changes in operating assets and liabilities, net of acquired assets and assumed liabilities: | | | | | |
Accounts receivable | (178,432) | | | (251,390) | | | 201,706 | |
Inventories | (123,752) | | | 1,320 | | | (48,046) | |
Prepaid and other current assets | (106,396) | | | (89,983) | | | (102,174) | |
Other long-term assets | (100,618) | | | (15,283) | | | (153,037) | |
Accounts payable and accrued liabilities | 170,496 | | | (34,066) | | | 125,133 | |
Operating lease liabilities | (73,281) | | | (85,828) | | | (82,581) | |
Income taxes | 198,078 | | | 1,644 | | | 28,855 | |
Deferred revenue | (113,435) | | | 414,251 | | | 160,325 | |
Net cash provided by operating activities | 1,703,274 | | | 1,738,900 | | | 1,492,622 | |
Cash flows from investing activities: | | | | | |
Proceeds from sales and maturities of short-term investments | 130,435 | | | 93,696 | | | 12,850 | |
Purchases of short-term investments | (131,079) | | | (97,245) | | | (161,732) | |
Proceeds from sales of long-term investments | 8,492 | | | 582 | | | — | |
Purchases of long-term investments | (435) | | | (7,000) | | | (7,591) | |
| | | | | |
Purchases of property and equipment | (189,618) | | | (136,589) | | | (93,764) | |
Acquisitions, net of cash acquired | (297,692) | | | (422,374) | | | (296,017) | |
Capitalization of software development costs | (2,204) | | | (2,493) | | | (1,976) | |
Other | — | | | (1,200) | | | (800) | |
Net cash used in investing activities | (482,101) | | | (572,623) | | | (549,030) | |
Cash flows from financing activities: | | | | | |
| | | | | |
Repayment of debt | (2,603) | | | (76,838) | | | (28,061) | |
Issuances of common stock | 252,986 | | | 237,956 | | | 210,719 | |
Payments for taxes related to net share settlement of equity awards | (241,408) | | | (174,005) | | | (138,950) | |
Purchase of equity forward contract | (45,000) | | | — | | | (35,000) | |
Purchases of treasury stock | (1,160,724) | | | (1,100,000) | | | (753,081) | |
Other | (122) | | | (3,413) | | | (4,375) | |
Net cash used in financing activities | (1,196,871) | | | (1,116,300) | | | (748,748) | |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (2,979) | | | (65,296) | | | 2,369 | |
Net change in cash, cash equivalents and restricted cash | 21,323 | | | (15,319) | | | 197,213 | |
Cash, cash equivalents and restricted cash, beginning of year | 1,419,864 | | | 1,435,183 | | | 1,237,970 | |
Cash, cash equivalents and restricted cash, end of year | $ | 1,441,187 | | | $ | 1,419,864 | | | $ | 1,435,183 | |
Supplemental disclosure of cash flow information: | | | | | |
Cash paid for income taxes during the year: | $ | 97,956 | | | $ | 167,768 | | | $ | 149,762 | |
Interest payments during the year: | $ | 996 | | | $ | 1,258 | | | $ | 3,365 | |
Non-cash activities: | | | | | |
Purchase of property and equipment included in accounts payable | $ | 21,672 | | | $ | 17,857 | | | $ | 8,654 | |
Conversion of notes receivable to non-marketable equity securities | $ | 2,000 | | | $ | 14,280 | | | $ | — | |
See the accompanying Notes to Consolidated Financial Statements.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1. Description of Business
Synopsys, Inc. (Synopsys, we, our or us) provides products and services used across the entire Silicon to Software spectrum to bring Smart Everything to life. From engineers creating advanced semiconductors to product teams developing advanced electronic systems to software developers seeking to ensure the security and quality of their code, our customers trust that our technologies will enable them to meet new requirements for energy efficiency, reliability, mobility, security and more.
We are a global leader in supplying the electronic design automation (EDA) software that engineers use to design and test integrated circuits (ICs), also known as chips or silicon. We provide software and hardware used to validate the electronic systems that incorporate chips and the software that runs on them, including cloud-based digital design flow to boost chip-design development productivity. We also provide technical services and support to help our customers develop advanced chips and electronic systems. These products and services are part of our Design Automation segment.
We also offer a broad and comprehensive portfolio of semiconductor intellectual property (IP) products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves. These products and services are part of our Design IP segment.
We are also a leading provider of software tools and services that improve the security, quality and compliance of software in a wide variety of industries, including electronics, financial services, automotive, medicine, energy and industrials. These tools and services are part of our Software Integrity segment.
Note 2. Summary of Significant Accounting Policies and Basis of Presentation
Basis of Presentation and Principles of Consolidation. Our fiscal year generally ends on the Saturday nearest to October 31 and consists of 52 weeks, with the exception that approximately every five years, we have a 53-week year. When a 53-week year occurs, we include the additional week in the first quarter to realign fiscal quarters with calendar quarters. Fiscal 2023, 2022 and 2021 were 52-week years ending on October 28, 2023, October 29, 2022, and October 30, 2021, respectively. For presentation purposes, the consolidated financial statements and accompanying notes refer to the closest calendar month end. Fiscal 2024 will be a 53-week year.
The consolidated financial statements include our accounts and the accounts of our wholly and majority-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates. To prepare financial statements in conformity with U.S. generally accepted accounting principles, management must make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates and could have a material impact on our operating results and financial position.
Comparability. Effective beginning of fiscal 2022, we adopted an Accounting Standards Update (ASU) to simplify the accounting for income taxes in Accounting Standards Codification (ASC) 740, Income Taxes, on a prospective basis. Effective beginning the second quarter of fiscal 2022, we early adopted an ASU, on a prospective basis, to apply revenue guidance to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination on the acquisition date, instead of measuring them at fair value. The adoption of these updates did not have a material impact on our consolidated financial statements. Effective in the first quarter of fiscal 2023, we changed our reportable segments from two reportable segments to three reportable segments, as described in Segment Reporting policy below.
Certain reclassifications have been made to the prior year's consolidated financial statements to conform to the current year presentation. The reclassifications, including the segment change, did not have a material impact on the prior year's consolidated balance sheets, statements of income, statements of comprehensive income and statements of cash flows.
Cash Equivalents and Short-term Investments. We consider all highly liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents. Our investments in debt securities with remaining maturities greater than three months at the date of purchase are designated as available-for-sale securities as we may convert these investments into cash at any time to fund general operations, and included in
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
short-term investments on the consolidated balance sheet. Our debt securities generally have an effective maturity term of less than three years and are carried at fair value, with unrealized gains and losses included in the consolidated balance sheets as a component of accumulated other comprehensive income (loss). For available-for-sale debt securities in an unrealized loss position, we evaluate whether a current expected credit loss exists based on available information relevant to the credit rating of the security, current economic conditions and reasonable and supportable forecasts. The allowance for credit loss is recorded in other income (expense), net, on the consolidated statements of income, not to exceed the amount of the unrealized loss. Any excess unrealized loss other than the credit loss is recognized in accumulated other comprehensive income or loss in the stockholders' equity section of the consolidated balance sheets. The cost of securities sold is based on the specific identification method and realized gains and losses are included in other income (expense), net. See Note 7. Financial Assets and Liabilities of the Notes to Consolidated Financial Statements.
Investments in Equity Securities. We hold equity securities in privately held companies for the promotion of business and strategic objectives. We account for these investments using either the measurement alternative approach when the fair value of the investment is not readily determinable and we do not have the ability to exercise significant influence, or the equity method of accounting when it is determined that we have the ability to exercise significant influence. Investments accounted for using the measurement alternative approach are initially recorded at cost and adjusted for changes in fair value from observable transactions. For investments accounted for using the equity method of accounting, we record our proportionate share of the investee’s income or loss to other income (expense), net, in our consolidated statements of income. These investments are subject to a periodic impairment review, and are included in other long-term assets on the consolidated balance sheets.
Accounts Receivable, Net. The balances consist of billed accounts receivable and current portion of unbilled accounts receivable. Trade accounts receivable are recorded at the invoiced amount and do not bear interest.
Allowance for Credit Losses. We maintain an allowance for credit losses for expected uncollectible accounts receivable and contract assets, which is recorded as an offset to accounts receivable or contract assets and provisions for credit losses are recorded in general and administrative expense in the consolidated statements of income. The allowance for current expected credit losses is based on a review of customer accounts and considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. The allowance for credit losses is reviewed on a quarterly basis to assess the adequacy of the allowance. The following table presents the changes in the allowance for credit losses:
| | | | | | | | | | | | | | | | | | | | | | | |
Fiscal Year | Balance at Beginning of Period | | Provisions | | Write-offs/Adjustments | | Balance at End of Period |
| (in thousands) |
2023 | $ | 41,236 | | | $ | 19,932 | | | $ | (6,763) | | | $ | 54,405 | |
2022 | $ | 31,605 | | | $ | 12,424 | | | $ | (2,793) | | | $ | 41,236 | |
2021 | $ | 29,489 | | | $ | 18,515 | | | $ | (16,399) | | | $ | 31,605 | |
Inventories. Inventories are computed at standard costs which approximate actual costs, on a first-in, first-out basis and valued at the lower of cost or net realizable value. Inventories primarily include components and finished goods for complex emulation and prototyping hardware systems. The valuation process includes a review of the forecasts based upon future demand and market conditions. Inventory provisions are recorded when the costs are determined to be in excess of anticipated demand or considered obsolete. Inventory provisions are impacted by market and economic conditions, technology changes, new product introductions and changes in strategic direction, and require estimates that may include uncertain elements.
Fair Values of Financial Instruments. Our cash equivalents, short-term investments and foreign currency contracts are carried at fair value. The fair value of our accounts receivable and accounts payable approximates the carrying amount due to their short duration. Non-marketable equity securities are accounted for using either the measurement alternative or equity method of accounting. We perform periodic impairment analysis on these non-marketable equity securities. The carrying amount of the short-term and long-term debt approximates the estimated fair value. See Note 8. Fair Value Measurements of the Notes to Consolidated Financial Statements.
Foreign Currency Contracts. We operate internationally and are exposed to potentially adverse movements in currency exchange rates. We enter into hedges in the form of foreign currency forward contracts to reduce our
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
exposure to foreign currency rate changes on non-functional currency denominated forecasted transactions and balance sheet positions. The assets or liabilities associated with the forward contracts are recorded at fair value in other current assets or accrued liabilities in the consolidated balance sheets.
The accounting for gains and losses resulting from changes in fair value depends on the use of the foreign currency forward contract and whether it is designated and qualifies for hedge accounting. See Note 7. Financial Assets and Liabilities of the Notes to Consolidated Financial Statements.
Concentration of Credit Risk. Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash equivalents, short-term investments, foreign currency contracts, and trade accounts receivable. We maintain cash equivalents primarily in highly rated taxable and tax-exempt money market funds located in the U.S. and in various overseas locations. Our short-term investments include a variety of financial instruments, such as corporate debt and municipal securities, U.S. Treasury and Government agency securities. By policy, we limit the amount of credit exposure with any one issue, issuer and type of instrument.
We sell our products worldwide primarily to customers in the global electronics market. We perform on-going credit evaluations of our customers’ financial condition and do not require collateral. We establish reserves for potential credit losses and such losses have been within management’s expectations and have not been material in any year presented.
Income Taxes. We account for income taxes using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
We account for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining whether it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. An uncertain tax position is considered effectively settled on completion of an examination by a taxing authority if certain other conditions are satisfied.
Property and Equipment. Property and equipment is recorded at cost less accumulated depreciation. Assets, excluding land, are depreciated using the straight-line method over their estimated useful lives. Depreciation expenses were $145.1 million, $107.7 million and $119.1 million in fiscal 2023, 2022 and 2021, respectively. Repair and maintenance costs are expensed as incurred and such costs were $84.0 million, $72.9 million and $62.6 million in fiscal 2023, 2022 and 2021, respectively.
The useful lives of depreciable assets are as follows: | | | | | |
| Useful Life in Years |
Computer and other equipment | 3 - 8 |
Buildings | 30 |
Furniture and fixtures | 5 |
Leasehold improvements | Shorter of the lease term or the estimated useful life |
Leases. We determine if an arrangement is a lease at inception of the contract, which is the date on which the terms of the contract are agreed to, and the agreement creates enforceable rights and obligations. A contract is or contains a lease when we have the right to control the use of an identified asset for a period of time. The commencement date of the lease is the date that the lessor makes an underlying asset available for use by the lessee. On the commencement date, leases are evaluated for classification and assets and liabilities are recognized based on the present value of lease payments over the lease term.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
The lease term used to calculate the lease liability includes options to extend or terminate the lease when it is reasonably certain that the option will be exercised. The right of use (ROU) asset is initially measured as the amount of lease liability, adjusted for any initial lease costs, prepaid lease payments and any lease incentives. Variable lease payments, consisting primarily of reimbursement of costs incurred by lessors for common area maintenance, real estate taxes and insurance, are not included in the lease liability and are recognized as they are incurred.
As most of our leases do not provide an implicit rate, we use the incremental borrowing rate at lease commencement to measure ROU assets and lease liabilities. We use a benchmark senior unsecured yield curve for debt instruments over the similar term, and consider specific credit quality, market conditions, tenor of lease arrangements, and quality of collateral to determine the incremental borrowing rate.
Operating lease expense is generally recognized on a straight-line basis over the lease term. We have elected the practical expedient to account for the lease and non-lease components as a single lease component for the majority of our asset classes. For leases with an initial term of one year or less, we have elected not to record the ROU asset or liability.
Business Combinations. We allocate the purchase price of acquired companies to the tangible and intangible assets acquired and liabilities assumed based on their acquisition-date fair values with the exception of contract assets and contract liabilities (deferred revenue) which are recognized and measured on the acquisition date in accordance with our “Revenue Recognition” policy. The excess of the fair value of purchase consideration over the fair value of these identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. We include the results of operations of the businesses that are acquired from the acquisition date.
Goodwill. Goodwill represents the excess of the aggregate purchase price over the fair value of the net tangible and identifiable intangible assets acquired by us. The carrying amount of goodwill at each reporting unit is tested for impairment annually on the first day of the fourth fiscal quarter, or more frequently if facts and circumstances warrant a review. We perform either a qualitative or quantitative assessment for goodwill impairment test. When a quantitative goodwill impairment assessment is performed, we use an income approach based on discounted cash flow analysis, a market approach based on market multiples, or a combination of both. If the fair value of a reporting unit is less than its carrying value, a goodwill impairment loss is recorded for the difference.
There was no goodwill impairment in fiscal 2023, 2022 and 2021.
Intangible Assets. Intangible assets consist of acquired technology, certain contract rights, customer relationships, trademarks and trade names, and capitalized software. These intangible assets are acquired through business combinations, direct purchases, or internally developed capitalized software. Intangible assets are amortized on a straight-line basis over their estimated useful lives which range from one to ten years.
We review the carrying values of long-lived assets including intangible assets whenever events or changes in circumstances indicate that the carrying value may not be fully recoverable. Recoverability of long-lived assets is measured by comparing the carrying value of such asset group to the future undiscounted cash flows that asset group is expected to generate. If the undiscounted future cash flow is less than the carrying amount of the asset group, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the asset group. There were no impairment charges for long-lived assets in fiscal 2023, 2022 and 2021.
Redeemable Non-controlling Interest. Non-controlling interest that is not solely redeemable within our control is reported as temporary equity in our consolidated balance sheets. The carrying value of the redeemable non-controlling interest equals the redemption value at the end of each reporting period, after giving effect to the change from the net income (loss) attributable to the redeemable non-controlling interest. We remeasure the redemption value of the non-controlling interest on a quarterly basis and changes in the estimated redemption value are recognized through retained earnings and may also impact the net income or loss attributable to common stockholders of Synopsys if the redemption value falls below a stated threshold. See Note 4. Business Combinations of the Notes to Consolidated Financial Statements for more information regarding the redeemable non-controlling interests.
Revenue Recognition. We recognize revenue for the transfer of services or products to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those services or products. The
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
principle is achieved through the following five-step approach:
•Identification of the contract, or contracts, with the customer
•Identification of the performance obligation in the contract
•Determination of the transaction price
•Allocation of the transaction price to the performance obligations in the contract
•Recognition of revenue when, or as, we satisfy a performance obligation
Nature of Products and Services
We generate revenue from the licensing of our EDA software, IP Blocks, and Software Integrity products, as well as sale of hardware products, and maintenance and services. The various types are set forth below.
Electronic Design Automation
Software license revenue consists of fees associated with the licensing of our software primarily through Technology Subscription License (TSL) contracts. TSLs are time-based licenses for a finite term and generally provide the customer with limited rights to receive, or to exchange certain quantities of licensed software for, unspecified future technology. The majority of our arrangements are TSLs due to the nature of our business and customer requirements. In addition to the licenses, the arrangements also include: post-contract customer support, which includes providing frequent updates and upgrades to maintain the utility of the software due to rapid changes in technology; other intertwined services such as multiple copies of the tools; assisting our customers in applying our technology in the customers' development environment; and rights to remix licenses for other licenses. Payments are generally received in equal or near equal installments over the term of the arrangement. We have concluded that our software licenses in TSL contracts are not distinct from our obligation to provide unspecified software updates to the licensed software throughout the license term. Such updates represent inputs to a single, combined performance obligation, commencing upon the later of the arrangement effective date or transfer of control to the software license. Remix rights are not an additional promised good or service in the contract, and where unspecified additional software product rights are part of the contract with the customer, such rights are accounted for as part of the single performance obligation that includes the licenses, updates, and technical support because such rights are provided for the same period of time and have the same pattern of transfer to the customer over the duration of the subscription term.
Design IP Products
We generally license IP under nonexclusive license agreements that provide usage rights for specific applications. Additionally, for certain IP license agreements, royalties are collected as customers sell their own products that incorporate our IP. These arrangements generally have two distinct performance obligations that consist of transferring the licensed IP and the post contract support service. Support services consist of a stand-ready obligation to provide technical support and software updates over the support term. Revenue allocated to the IP license is recognized at a point in time upon the later of the delivery date or the beginning of the license period, and revenue allocated to support services is recognized ratably over the support term. Royalties are recognized as revenue is earned, generally when the customer sells its products that incorporate our IP.
Software Integrity Products
Software Integrity product arrangements provide customers the right to software licenses, software updates and technical support. Under the term of these arrangements, the customer expects to receive integral updates to the software licenses that protect the customer’s software from potential security vulnerabilities. The licenses and software updates together serve to fulfill our commitment to the customer, as they represent inputs to a single, combined performance obligation that commences upon the later of the arrangement effective date or transfer of the software license. Software updates are part of the contract with the customer, and such rights are accounted for as part of the single performance obligation that includes the licenses, updates, and technical support because such rights are provided for the same period of time and have the same time-based pattern of transfer to the customer.
Hardware
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
We generally have two performance obligations in arrangements involving the sale of hardware products. The first performance obligation is to transfer the hardware product, which includes embedded software integral to the functionality of the hardware product. The second performance obligation is to provide maintenance on the hardware and our embedded software, including rights to technical support, hardware repairs and software updates that are all provided over the same term and have the same time-based pattern of transfer to the customer. The portion of the transaction price allocated to the hardware product is recognized as revenue at a point in time when control of the hardware is transferred to the customer. We have concluded that control generally transfers upon shipment because the customer has the ability to direct the use of the asset and an obligation to pay for the hardware. The portion of the transaction price allocated to maintenance is recognized as revenue that is ratable over the maintenance term.
Professional Services
Our arrangements often include service elements (other than maintenance and support services). These services include training, design assistance, and consulting. These services are generally performed on a time and materials basis, and are recognized over time, as the customer simultaneously receives and consumes the benefit provided. Certain arrangements also include the customization or modification of licensed IP. Revenue from these contracts is recognized over time as the services are performed, when the development is specific to the customer’s needs and we have enforceable rights to payment for performance completed. Inputs such as costs incurred and hours expended are used in order to measure progress of performance. We have a history of accurately estimating project status and the costs necessary to complete projects. A number of internal and external factors can affect these estimates, including labor rates, utilization and efficiency variances, specification and testing requirement changes, and changes in customer delivery priorities. Payments for services are generally due upon milestones in the contract or upon consumption of the hourly resources.
Flexible Spending Accounts
Our customers frequently enter into non-cancelable Flexible Spending Account arrangements (FSA) whereby the customer commits to a fixed dollar amount over a specified period of time that can be used to purchase from a list of our products or services. These arrangements do not meet the definition of a revenue contract until the customer executes a separate order (pulldown request) to identify the required products and services that they are purchasing. The combination of the FSA arrangement and the subsequent order creates enforceable rights and obligations, thus meeting the definition of a revenue contract. Each separate order under the agreement is treated as an individual contract and accounted for based on the respective performance obligations included within the pulldown requests.
Significant Judgments
Our contracts with customers often include promises to transfer multiple products and services to a customer. Determining whether services and products are considered distinct performance obligations that should be accounted for separately versus together requires significant judgment. We have concluded that (1) our EDA software licenses in TSL contracts are not distinct from our obligation to provide unspecified software updates to the licensed software throughout the license term, because those promises represent inputs to a single, combined performance obligation, and (2) where unspecified additional software product rights are part of the contract with the customer, such rights are accounted for as part of the single performance obligation that includes the licenses, updates, and technical support, because such rights are provided for the same period of time and have the same time-based pattern of transfer to the customer. In reaching this conclusion, we considered the nature of the obligation to customers which is to provide an ongoing right to use the most up to date and relevant software. As EDA customers operate in a rapidly changing and competitive environment, satisfying the obligation requires providing critical updates to the existing software products, including ongoing iterative interaction with customers to make the software relevant to customers’ ability to meet the time to go to market with advanced products.
Similarly, we also concluded that in our Software Integrity business, the licenses and maintenance updates serve together to fulfill our commitment to the customer as both work together to provide the functionality to the customer and represent a combined performance obligation because the updates are essential to the software’s central utility, which is to identify security vulnerabilities and other threats.
Our contracts with customers can involve hundreds of products and various license rights. Customers often negotiate a broad portfolio of solutions, and favorable terms along with future purchase options to manage their
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
overall costs. Determining whether the purchase options are considered distinct performance obligations that should be accounted for separately as material rights versus combined together may require significant judgment.
Judgment is also required to determine the standalone selling price (SSP) for each distinct performance obligation. For non-software performance obligations (IP, Hardware, and services), SSP is established based on observable prices of products and services sold separately. SSP for license (and related updates and support) in a contract with multiple performance obligations is determined by applying a residual approach whereby all other non-software performance obligations within a contract are first allocated a portion of the transaction price based upon their respective SSP, using observable prices, with any residual amount of the transaction price allocated to the license because we do not sell the license separately, and the pricing is highly variable.
Contract Balances
The timing of revenue recognition may differ from the timing of invoicing customers, and these timing differences result in receivables (billed or unbilled), contract assets, or contract liabilities (deferred revenue) on our consolidated balance sheet. We record a contract asset when revenue is recognized prior to the right to invoice, or deferred revenue when revenue is recognized subsequent to invoicing. For time-based software agreements, customers are generally invoiced in equal, quarterly amounts, although some customers prefer to be invoiced in single or annual amounts. We record an unbilled receivable when revenue is recognized and we have an unconditional right to invoice and receive payment.
Warranties and Indemnities
Warranties. We generally warrant our products to be free from defects in media and to substantially conform to material specifications for a period of 90 days for our software products and for up to six months for our hardware products.
Indemnities. In addition to such warranties, in certain cases, we provide our customers with limited indemnification with respect to claims that their use of our software products infringes on patents, copyrights, trademarks or trade secrets. For example, in connection with a litigation campaign launched by Bell Semiconductor LLC (Bell Semic), a patent monetization entity, some customers have requested defense and indemnification against claims of patent infringement asserted by Bell Semic in various district court litigations and at the U.S. International Trade Commission. Bell Semic alleges that the customers’ use of one or more features of certain of our products infringes one or more of six patents held by Bell Semic. We have offered to defend some of our customers consistent with the terms of our End User License Agreement. We are unable to estimate the potential impact of these commitments on the future results of operations.
Net Income Per Share. We compute basic net income per share by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted net income per share reflects the dilution from potential common shares outstanding such as stock options and unvested restricted stock units and awards during the period using the treasury stock method. See Note 14. Net Income Per Share of the Notes to Consolidated Financial Statements.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Foreign Currency Translation. The functional currency of the majority of our active foreign subsidiaries is the foreign subsidiary’s local currency. Assets and liabilities that are not denominated in the functional currency are remeasured into the functional currency with any related gains or losses recorded in earnings. We translate assets and liabilities of our non-U.S. dollar functional currency foreign operations into the U.S. dollar reporting currency at exchange rates in effect at the balance sheet date. We translate income and expense items of such foreign operations into the U.S. dollar reporting currency at average exchange rates for the period. Accumulated translation adjustments are reported in stockholders’ equity, as a component of accumulated other comprehensive income (loss).
Segment Reporting. Effective in the first quarter of fiscal 2023, we realigned our organizational structure to evaluate the results of our Design IP business separately. Our Chief Operating Decision Maker (CODM), our Chief Executive Officer (CEO), now regularly reviews disaggregated segment information, assesses performance against our key growth strategies and allocates resources based on this new organizational structure. As a result, effective in the first quarter of fiscal 2023, we changed our reportable segments from two reportable segments to the following three reportable segments: (1) Design Automation, which includes our advanced silicon design, verification products and services, system integration products and services, digital, custom and FPGA IC design software, verification software and hardware products, manufacturing software products and other; (2) Design IP, which includes our Design IP products; and (3) Software Integrity, which includes solutions that test software code for security vulnerabilities and quality defects, as well as professional and managed services. As such, prior period reportable segment results and related disclosures have been reclassified to reflect our current reportable segments.
Recently Adopted Accounting Pronouncements
In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2019-12, Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. We adopted the standard as of the beginning of fiscal 2022 on a prospective basis and the adoption did not have a material impact on our consolidated financial statements.
Beginning in fiscal 2021, we adopted ASC 326, which was issued by the FASB in June 2016 as ASU 2016-13 Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments. The ASU replaced previous incurred loss impairment guidance and established a single expected credit losses allowance framework for financial assets carried at amortized cost. It also eliminated the concept of other-than-temporary impairment and requires credit losses related to certain available-for-sale debt securities to be recorded through an allowance for credit losses. We adopted ASC 326 using the modified retrospective method, which requires a cumulative-effect adjustment to the opening balance of retained earnings to be recognized on the date of adoption and, accordingly, recorded a net decrease of $3.2 million to retained earnings as of beginning of fiscal 2021. Please see the “Allowance for Credit Losses” accounting policy above.
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if the acquirer had originated the contracts. We early adopted the standard in the second quarter of fiscal 2022 on a prospective basis, and the adoption did not have a material impact on our consolidated financial statements.
There have been no recently adopted accounting pronouncements during fiscal 2023 that are of significance to us.
Recent Accounting Pronouncements Not Yet Adopted
In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (ASU 2022-03), which applies to all equity securities measured at fair value that are subject to contractual sale restrictions. This change prohibits entities from taking into account contractual restrictions on the sale of equity securities when estimating fair value and introduces required disclosures for such transactions. The standard will become effective for us beginning on November 1, 2024 and will be applied prospectively. Early adoption is permitted. Any future impact from the adoption of this guidance will depend on the facts and circumstances of future transactions.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07). The ASU expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. The ASU is effective for us beginning on November 1, 2024 and will be applied retrospectively. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU on our consolidated financial statements and disclosures.
Note 3. Revenue
Disaggregated Revenue
The following table shows the percentage of revenue by product groups:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
EDA | 62.9 | % | | 62.9 | % | | 63.6 | % |
Design IP | 26.4 | % | | 25.9 | % | | 25.1 | % |
Software Integrity | 9.0 | % | | 9.2 | % | | 9.4 | % |
Other | 1.7 | % | | 2.0 | % | | 1.9 | % |
Total | 100.0 | % | | 100.0 | % | | 100.0 | % |
Contract Balances
The contract assets indicated below are presented as prepaid and other current assets in the consolidated balance sheets. The contract assets are transferred to receivables when the rights to invoice and receive payment become unconditional. Unbilled receivables are presented as accounts receivable, net, in the consolidated balance sheets.
Contract balances are as follows: | | | | | | | | | | | |
| As of October 31, |
| 2023 | | 2022 |
| (in thousands) |
Contract assets, net | $ | 389,042 | | | $ | 260,498 | |
Unbilled receivables | $ | 60,016 | | | $ | 46,254 | |
Deferred revenue | $ | 1,951,128 | | | $ | 2,065,294 | |
During fiscal 2023, we recognized revenue of $1.7 billion, including previously unfulfilled contracts that have expired and are no longer subject to an implied promise to provide future services, that was included in the deferred revenue balance as of October 31, 2022. During fiscal 2022, we recognized revenue of $1.2 billion that was included in the deferred revenue balance as of October 31, 2021.
Contracted but unsatisfied or partially unsatisfied performance obligations (backlog) were approximately $8.6 billion as of October 31, 2023, which includes $1.4 billion in non-cancellable Flexible Spending Account (FSA) commitments from customers where actual product selection and quantities of specific products or services are to be determined by customers at a later date. We have elected to exclude future sales-based royalty payments from the remaining performance obligations. Approximately 40% of the backlog as of October 31, 2023, excluding non-cancellable FSA, is expected to be recognized as revenue over the next 12 months. The majority of the remaining backlog is expected to be recognized in the following three years. The backlog was approximately $7.1 billion as of October 31, 2022, which included $1.1 billion in non-cancellable FSA commitments from customers.
During fiscal 2023 and 2022, we recognized $99.3 million and $137.3 million, respectively, from performance obligations satisfied from sales-based royalties earned during the periods.
Costs of Obtaining a Contract with Customer
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
The incremental costs of obtaining a contract with a customer, which consist primarily of direct sales commission earned upon execution of the contract, were capitalized in compliance with authoritative guidance, and amortized over the estimated period of which the benefit is expected to be received. As direct sales commission paid for renewals are commensurate with the amounts paid for initial contracts, the deferred incremental costs will be recognized over the contract term.
Capitalized commission costs, net of accumulated amortization, as of October 31, 2023 and 2022 were $88.6 million and $96.5 million, respectively. The balances are included in other long-term assets in our consolidated balance sheets. Amortization of these assets were $82.2 million, $73.0 million and $64.7 million during fiscal 2023, 2022 and 2021, respectively, and are included in sales and marketing expense in our consolidated statements of income.
Note 4. Business Combinations
Fiscal 2023
During fiscal 2023, we completed several acquisitions for an aggregate purchase consideration of $295.4 million, net of cash acquired. The aggregate purchase consideration was preliminary and allocated as follows: $95.8 million to identifiable intangible assets, $229.4 million to goodwill, and $29.8 million to net tangible liabilities. The acquired identifiable intangible assets were valued using the income approach and are being amortized over their respective useful lives ranging from 1 to 8 years. The goodwill recognized from these acquisitions was assigned to the Design Automation reporting unit, of which $5.7 million was deductible for income tax purposes.
We have included the financial results of the fiscal 2023 acquisitions in our consolidated financial statements from their respective acquisition date. We do not consider these acquisitions to be material, individually or in the aggregate, to our consolidated financial statements.
Fiscal 2022
NTT Security AppSec Solutions Inc.
On June 22, 2022, we completed the acquisition of all outstanding shares of NTT Security AppSec Solutions Inc. (which operated under the name WhiteHat Security, or WhiteHat), a provider of dynamic application security testing solutions, from NTT Security Corporation for an aggregate purchase price of $310.0 million, net of cash acquired. With this acquisition, we broadened our product offering in the application security testing market.
The aggregate purchase consideration was allocated as follows: $97.5 million to identifiable intangible assets, $252.9 million to goodwill, and $40.4 million to net tangible liabilities. The goodwill was assigned to the Software Integrity reporting unit and the amount recognized was not deductible for tax purposes. The acquired identifiable intangible assets of $97.5 million were valued using the income approach and are being amortized over their respective useful lives ranging from 5 to 10 years.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
OpenLight Photonics, Inc.
During the second quarter of fiscal 2022, we acquired a 75% equity interest in OpenLight Photonics, Inc. (OpenLight) for cash consideration of $90.0 million. The remaining 25% equity interest in OpenLight is held by Juniper Networks, Inc. (the Minority Investor) from their contribution of IP and certain tangible assets.
The agreement with the Minority Investor contains redemption features whereby the interest held by the Minority Investor is redeemable either (i) at the option of the Minority Investor on or after the third anniversary of the acquisition or sooner in certain circumstances or (ii) at our option beginning on the third anniversary of the acquisition. This option is exercisable at the greater of fair value at the time of redemption or $30.0 million and was valued at $10.1 million, resulting in a total consideration of $100.1 million.
The purchase price was allocated as follows: $94.0 million to identifiable intangible assets and $46.7 million to goodwill, which were attributable to the Design Automation reporting unit. There was no tax-deductible goodwill related to the acquisition.
During fiscal 2023, our ownership interest in OpenLight was reduced to 73% as a result of the recognition of non-controlling interest upon issuance of OpenLight stock.
During fiscal 2023, OpenLight incurred a net loss of $40.9 million, of which $10.0 million was attributable to redeemable non-controlling interest. As of October 31, 2023, the carrying value of the redeemable non-controlling interest was $31.0 million in the consolidated balance sheets.
Other Fiscal 2022 Acquisitions
During fiscal 2022, we completed two other acquisitions for aggregate purchase consideration of $31.8 million, net of cash acquired. The purchase price was allocated as follows: $12.7 million to identifiable intangible assets, $3.1 million to net tangible liabilities, and $22.2 million to goodwill, which were attributable to the Design Automation reporting unit. There was no tax-deductible goodwill related to the acquisitions.
Fiscal 2021
During fiscal 2021, we completed several acquisitions for an aggregate consideration of $298.9 million, net of cash acquired. We do not consider these acquisitions to be material, individually or in the aggregate, to our consolidated financial statements. Total purchase consideration was allocated as follows: $109.3 million to identifiable intangible assets, $16.2 million to net tangible liabilities, and $205.8 million to goodwill, of which $150.4 million was attributable to the Design Automation reporting unit, $9.7 million was attributable to the Designed IP reporting unit, and $45.7 million was attributable to the Software Integrity reporting unit.
Approximately $34.0 million of the goodwill related to the fiscal 2021 acquisitions was deductible for tax purposes.
Preliminary Fair Value Estimates
For all acquisitions completed in fiscal 2023, the purchase price was allocated to tangible and identifiable intangible assets acquired and liabilities assumed based on their preliminary estimated fair values, which were determined using generally accepted valuation techniques based on estimates and assumptions made by management at the time of acquisition. These estimates and assumptions are subject to change as additional information becomes available during the respective measurement period, which is not expected to exceed 12 months from applicable acquisition date. The primary areas of those preliminary estimates relate to certain tangible assets and liabilities, identifiable intangible assets, and income taxes.
Acquisition-Related Transaction Costs
Acquisition-related transaction costs were $15.1 million, $14.1 million and $15.4 million during fiscal 2023, 2022 and 2021, respectively. These costs consist of professional fees and administrative costs and were expensed as incurred in our consolidated statements of income.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Note 5. Goodwill and Intangible Assets
Goodwill
Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in business combinations. As a result of the change in reporting units effective in the first quarter of fiscal 2023, we have three reportable segments, and reporting units are determined to be the same as reportable segments. We performed a quantitative impairment assessment by estimating the fair value of our new reporting units and reallocating goodwill to the reporting units using a relative fair value method. No impairment of goodwill was identified before and after the change in reporting units. We also performed the required annual goodwill impairment test in the fourth quarter of fiscal 2023 and concluded that goodwill was not impaired.
Goodwill activity by reportable segment consists of the following: | | | | | | | | | | | | | | | | | | | | | | | |
| Design Automation | | Design IP | | Software Integrity | | Total |
| (in thousands) |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Balance at October 31, 2021 | $ | 2,156,732 | | | $ | 947,742 | | | $ | 471,311 | | | $ | 3,575,785 | |
Additions | 68,923 | | | — | | | 249,852 | | | 318,775 | |
Adjustments | 1,285 | | | — | | | — | | | 1,285 | |
Effect of foreign currency translation | (50,603) | | | (3,008) | | | — | | | (53,611) | |
Balance at October 31, 2022 | 2,176,337 | | | 944,734 | | | 721,163 | | | 3,842,234 | |
Additions | 229,351 | | | — | | | — | | | 229,351 | |
Adjustments | — | | | — | | | 3,097 | | | 3,097 | |
Effect of foreign currency translation | (5,006) | | | 649 | | | 11 | | | (4,346) | |
Balance at October 31, 2023 | $ | 2,400,682 | | | $ | 945,383 | | | $ | 724,271 | | | $ | 4,070,336 | |
Intangible Assets
Intangible assets as of October 31, 2023 consists of the following:
| | | | | | | | | | | | | | | | | |
| Gross Carrying Amount | | Accumulated Amortization | | Net Amount |
| (in thousands) |
Core/developed technology | $ | 1,135,347 | | | $ | 885,555 | | | $ | 249,792 | |
Customer relationships | 463,371 | | | 358,421 | | | 104,950 | |
Contract rights intangible | 194,930 | | | 190,670 | | | 4,260 | |
Trademarks and trade names | 52,825 | | | 37,633 | | | 15,192 | |
| | | | | |
Capitalized software development costs | 50,795 | | | 50,795 | | | — | |
| | | | | |
Total | $ | 1,897,268 | | | $ | 1,523,074 | | | $ | 374,194 | |
Intangible assets as of October 31, 2022 consists of the following:
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
| | | | | | | | | | | | | | | | | |
| Gross Carrying Amount | | Accumulated Amortization | | Net Amount |
| (in thousands) |
Core/developed technology | $ | 1,083,703 | | | $ | 813,226 | | | $ | 270,477 | |
Customer relationships | 426,242 | | | 333,984 | | | 92,258 | |
Contract rights intangible | 190,666 | | | 188,262 | | | 2,404 | |
Trademarks and trade names | 52,795 | | | 34,054 | | | 18,741 | |
| | | | | |
Capitalized software development costs | 48,591 | | | 46,025 | | | 2,566 | |
| | | | | |
Total | $ | 1,801,997 | | | $ | 1,415,551 | | | $ | 386,446 | |
Amortization expense related to intangible assets consists of the following:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
| (in thousands) |
Core/developed technology | $ | 72,412 | | | $ | 64,469 | | | $ | 46,049 | |
Customer relationships | 24,446 | | | 26,640 | | | 31,478 | |
Contract rights intangible | 2,452 | | | 2,682 | | | 2,413 | |
Trademarks and trade names | 3,579 | | | 2,899 | | | 2,440 | |
Capitalized software development costs(1) | 4,771 | | | 2,672 | | | 4,067 | |
| | | | | |
Total | $ | 107,660 | | | $ | 99,362 | | | $ | 86,447 | |
(1)Amortization of capitalized software development costs is included in cost of products revenue in the consolidated statements of income.
The following table presents the estimated future amortization of intangible assets as of October 31, 2023:
| | | | | |
Fiscal Year | (in thousands) |
2024 | $ | 103,108 | |
2025 | 84,588 | |
2026 | 71,406 | |
2027 | 51,205 | |
2028 | 25,807 | |
2029 and thereafter | 38,080 | |
| |
Total | $ | 374,194 | |
Note 6. Balance Sheet Components
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
| | | | | | | | | | | |
| As of October 31, |
| 2023 | | 2022 |
| (in thousands) |
Accounts receivable, net: | | | |
Accounts receivable | $ | 929,673 | | | $ | 779,390 | |
Unbilled accounts receivable | 60,016 | | | 46,254 | |
Total accounts receivable | 989,689 | | | 825,644 | |
Less: allowance for credit losses | (42,722) | | | (29,553) | |
Total | $ | 946,967 | | | $ | 796,091 | |
| | | |
Property and equipment, net: | | | |
Computer and other equipment | $ | 991,994 | | | $ | 870,388 | |
Buildings | 135,255 | | | 135,722 | |
Furniture and fixtures | 86,946 | | | 80,885 | |
Land | 21,598 | | | 21,598 | |
Leasehold improvements | 265,536 | | | 241,062 | |
| 1,501,329 | | | 1,349,655 | |
Less: accumulated depreciation (1) | (944,068) | | | (866,355) | |
Total | $ | 557,261 | | | $ | 483,300 | |
| | | |
Other long-term assets: | | | |
Deferred compensation plan assets | $ | 300,731 | | | $ | 279,096 | |
Capitalized commission, net | 88,614 | | | 96,509 | |
Other | 81,628 | | | 88,090 | |
Total | $ | 470,973 | | | $ | 463,695 | |
| | | |
Accounts payable and accrued liabilities: | | | |
Payroll and related benefits | $ | 583,854 | | | $ | 559,886 | |
Accrued income taxes | 226,762 | | | 35,290 | |
Other accrued liabilities | 157,254 | | | 176,647 | |
Accounts payable | 155,891 | | | 37,580 | |
Total | $ | 1,123,761 | | | $ | 809,403 | |
| | | |
Other long-term liabilities: | | | |
Deferred compensation plan liabilities | $ | 300,731 | | | $ | 279,096 | |
Other | 85,407 | | | 48,733 | |
Total | $ | 386,138 | | | $ | 327,829 | |
(1)Accumulated depreciation includes write-offs due to retirement of fully depreciated fixed assets.
Note 7. Financial Assets and Liabilities
Cash Equivalents and Short-term Investments
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
As of October 31, 2023, the balances of our cash equivalents and short-term investments are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses Less Than 12 Continuous Months | | Gross Unrealized Losses 12 Continuous Months or Longer | | Estimated Fair Value(1) |
| (in thousands) |
Cash equivalents: | | | | | | | | | |
Money market funds | $ | 10,129 | | | $ | — | | | $ | — | | | $ | — | | | $ | 10,129 | |
| | | | | | | | | |
U.S. Treasury, agency & T-bills | 2,994 | | | — | | | — | | | — | | | 2,994 | |
| | | | | | | | | |
Total: | $ | 13,123 | | | $ | — | | | $ | — | | | $ | — | | | $ | 13,123 | |
Short-term investments: | | | | | | | | | |
U.S. Treasury, agency & T-bills | $ | 15,752 | | | $ | — | | | $ | (61) | | | $ | (2) | | | $ | 15,689 | |
Municipal bonds | 515 | | | — | | | — | | | (16) | | | 499 | |
Corporate debt securities | 103,213 | | | 13 | | | (455) | | | (396) | | | 102,375 | |
Asset-backed securities | 33,245 | | | 21 | | | (93) | | | (97) | | | 33,076 | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Total: | $ | 152,725 | | | $ | 34 | | | $ | (609) | | | $ | (511) | | | $ | 151,639 | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
(1)See Note 8. Fair Value Measurements for further discussion on fair values.
Our short-term investment portfolio includes both corporate and government debt securities that have a maximum maturity of three years. The longer the duration of these securities, the more susceptible they are to changes in market interest rates and bond yields. As yields increase, those securities with a lower yield-at-cost show a mark-to-market unrealized loss. Most of our unrealized losses are due to changes in market interest rates, and bond yields. We believe that we have the ability to realize the full value of all of these investments upon maturity. As of October 31, 2023, our investments that were in a continuous loss position of 12 months or more, as well as the unrealized losses on those investments, were immaterial.
The contractual maturities of our available-for-sale debt securities as of October 31, 2023 are as follows:
| | | | | | | | | | | |
| Amortized Cost | | Fair Value |
| (in thousands) |
Less than 1 year | $ | 74,398 | | | $ | 73,879 | |
1-5 years | 74,604 | | | 74,104 | |
5-10 years | 1,723 | | | 1,721 | |
>10 years | 2,000 | | | 1,935 | |
Total | $ | 152,725 | | | $ | 151,639 | |
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
As of October 31, 2022, the balances of our cash equivalents and short-term investments are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses Less Than 12 Continuous Months | | Gross Unrealized Losses 12 Continuous Months or Longer | | Estimated Fair Value(1) |
| (in thousands) |
Cash equivalents: | | | | | | | | | |
Money market funds | $ | 77,683 | | | $ | — | | | $ | — | | | $ | — | | | $ | 77,683 | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Total: | $ | 77,683 | | | $ | — | | | $ | — | | | $ | — | | | $ | 77,683 | |
Short-term investments: | | | | | | | | | |
U.S. Treasury, agency & T-bills | $ | 25,816 | | | $ | — | | | $ | (174) | | | $ | (39) | | | $ | 25,603 | |
Municipal bonds | 2,970 | | | — | | | (12) | | | (80) | | | 2,878 | |
Corporate debt securities | 95,899 | | | 7 | | | (747) | | | (1,135) | | | 94,024 | |
Asset-backed securities | 25,826 | | | — | | | (149) | | | (269) | | | 25,408 | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Total: | $ | 150,511 | | | $ | 7 | | | $ | (1,082) | | | $ | (1,523) | | | $ | 147,913 | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
(1)See Note 8. Fair Value Measurements for further discussion on fair values.
Restricted cash
We include amounts generally described as restricted cash in cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the consolidated statements of cash flows. Restricted cash is primarily associated with office leases and employee loan programs.
The following table provides a reconciliation of cash, cash equivalents and restricted cash included in the consolidated balance sheets:
| | | | | | | | | | | |
| As of October 31, |
| 2023 | | 2022 |
| (in thousands) |
Cash and cash equivalents | $ | 1,438,913 | | | $ | 1,417,608 | |
Restricted cash included in prepaid and other current assets | 1,549 | | | 1,566 | |
Restricted cash included in other long-term assets | 725 | | | 690 | |
Total cash, cash equivalents and restricted cash | $ | 1,441,187 | | | $ | 1,419,864 | |
Non-marketable equity securities
Our portfolio of non-marketable equity securities consists of strategic investments in privately held companies. There were no material impairments of non-marketable equity securities in fiscal 2023, fiscal 2022, or fiscal 2021.
Derivatives
We recognize derivative instruments as either assets or liabilities in the consolidated balance sheets at fair value and provide qualitative and quantitative disclosures about such derivatives. We operate internationally and are exposed to potentially adverse movements in foreign currency exchange rates. We enter into hedges in the form of foreign currency forward contracts to reduce our exposure to foreign currency rate changes on non-functional currency denominated forecasted transactions and balance sheet positions including: (1) certain assets and liabilities, (2) shipments forecasted to occur within approximately one month, (3) future billings and revenue on previously shipped orders, and (4) certain future intercompany invoices denominated in foreign currencies.
The duration of forward contracts, the majority of which are short-term, ranges from approximately 1 month to 27 months at inception. We do not use foreign currency forward contracts for speculative or trading purposes. We enter into foreign exchange forward contracts with high credit quality financial institutions that are rated "A" or above and to date have not experienced nonperformance by counterparties. In addition, we mitigate credit risk in derivative
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
transactions by permitting net settlement of transactions with the same counterparty and anticipate continued performance by all counterparties to such agreements.
The assets or liabilities associated with the forward contracts are recorded at fair value in other current assets or accrued liabilities in the consolidated balance sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the foreign currency forward contract and whether it is designated and qualifies for hedge accounting. The cash flow impact upon settlement of the derivative contracts is included in “net cash provided by operating activities” in the consolidated statements of cash flows.
Cash Flow Hedging Activities
Certain foreign exchange forward contracts are designated and qualify as cash flow hedges. These contracts have durations of approximately 27 months or less. Certain forward contracts are rolled over periodically to capture the full length of exposure to our foreign currency risk, which can be up to three years. To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on the hedged transactions. The related gains or losses resulting from changes in fair value of these hedges is initially reported, net of tax, as a component of other comprehensive income (loss) (OCI) in stockholders’ equity and reclassified into revenue or operating expenses, as appropriate, at the time the hedged transactions affect earnings. We expect a majority of the hedge balance in OCI to be reclassified to the statements of income within the next 12 months.
We did not record any gains or losses related to discontinuation of cash flow hedges for fiscal years 2023, 2022 and 2021.
Non-designated Hedging Activities
Our foreign exchange forward contracts that are used to hedge non-functional currency denominated balance sheet assets and liabilities are not designated as hedging instruments. Accordingly, any gains or losses from changes in the fair value of the forward contracts are recorded in other income (expense), net. The gains and losses on these forward contracts generally offset the gains and losses associated with the underlying assets and liabilities, which are also recorded in other income (expense), net. The duration of the forward contracts for hedging our balance sheet exposure is approximately one month.
We also have certain foreign exchange forward contracts for hedging certain international revenues and expenses that are not designated as hedging instruments. Accordingly, any gains or losses from changes in the fair value of the forward contracts are recorded in other income (expense), net. The gains and losses on these forward contracts generally offset the gains and losses associated with the foreign currency in operating income. The duration of these forward contracts is usually less than one year. The overall goal of our hedging program is to minimize the impact of currency fluctuations on the net income over the fiscal year.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
The effects of the non-designated derivative instruments on our consolidated statements of income are summarized as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
| (in thousands) |
Gains (losses) recorded in other income (expense), net | $ | (5,899) | | | $ | (15,851) | | | $ | (855) | |
The notional amounts in the table below for derivative instruments provide one measure of the transaction volume outstanding:
| | | | | | | | | | | |
| As of October 31, |
| 2023 | | 2022 |
| (in thousands) |
Total gross notional amounts | $ | 1,666,758 | | | $ | 1,386,140 | |
Net fair value | $ | (2,308) | | | $ | (50,080) | |
Our exposure to the market gains or losses will vary over time as a function of currency exchange rates. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.
The following table represents the consolidated balance sheets location and amount of derivative instrument fair values segregated between designated and non-designated hedge instruments:
| | | | | | | | | | | |
| Fair values of derivative instruments designated as hedging instruments | | Fair values of derivative instruments not designated as hedging instruments |
| (in thousands) |
Balance at October 31, 2023 | | | |
Other current assets | $ | 12,962 | | | $ | 491 | |
Accrued liabilities | $ | 14,665 | | | $ | 1,096 | |
Balance at October 31, 2022 | | | |
Other current assets | $ | 2,315 | | | $ | 223 | |
Accrued liabilities | $ | 52,171 | | | $ | 447 | |
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
The following table represents the location of the amount of gains and losses on derivative instrument fair values for designated hedge instruments, net of tax in the consolidated statements of income:
| | | | | | | | | | | | | | | | | | | | | | | |
| Location of gains (losses) recognized in OCI on derivatives | | Amount of gains (losses) recognized in OCI on derivatives (effective portion) | | Location of gains (losses) reclassified from OCI | | Amount of gains (losses) reclassified from OCI (effective portion) |
| (in thousands) |
Fiscal year ended October 31, 2023 | | | | | | | |
Foreign exchange contracts | Revenue | | $ | 8,390 | | | Revenue | | $ | (9,942) | |
Foreign exchange contracts | Operating expenses | | 16,596 | | | Operating expenses | | (15,334) | |
Total | | | $ | 24,986 | | | | | $ | (25,276) | |
Fiscal year ended October 31, 2022 | | | | | | | |
Foreign exchange contracts | Revenue | | $ | (19,755) | | | Revenue | | $ | 10,975 | |
Foreign exchange contracts | Operating expenses | | (59,314) | | | Operating expenses | | (15,869) | |
Total | | | $ | (79,069) | | | | | $ | (4,894) | |
Fiscal year ended October 31, 2021 | | | | | | | |
Foreign exchange contracts | Revenue | | $ | 1,148 | | | Revenue | | $ | 4,181 | |
Foreign exchange contracts | Operating expenses | | 8,712 | | | Operating expenses | | 10,378 | |
Total | | | $ | 9,860 | | | | | $ | 14,559 | |
Other Commitments — Credit and Term Loan
On December 14, 2022, we entered into a Fifth Extension and Amendment Agreement (the Fifth Amendment), which amended and restated our previous credit agreement, dated as of January 22, 2021 (as amended and restated, the Credit Agreement).
The Fifth Amendment increased the existing senior unsecured revolving credit facility (the Revolver) from $650.0 million to $850.0 million and extended the maturity date from January 22, 2024 to December 14, 2027, which could be further extended at our option. The Credit Agreement also provides an uncommitted incremental revolving loan facility of up to $150.0 million in the aggregate principal amount. The Credit Agreement contains a financial covenant requiring us to maintain a maximum consolidated leverage ratio, as well as other non-financial covenants. As of October 31, 2023, we were in compliance with the financial covenant.
Borrowings bear interest at the adjusted term Secured Overnight Financing Rate (SOFR) plus an applicable margin between 0.785% and 0.975% based upon our consolidated leverage ratio. In addition, facility fees are payable on the Revolver at rates between 0.09% and 0.15% per year based on our leverage ratio on the daily amount of the revolving commitment.
There was no outstanding balance under the Revolver as of October 31, 2023 and October 31, 2022.
In July 2018, we entered into a 12-year 220.0 million Renminbi (approximately $33.0 million) credit agreement with a lender in China to support our facilities expansion. Borrowings bear interest at a floating rate based on the 5-year Loan Prime Rate plus 0.74%. As of October 31, 2023, we had a $18.1 million outstanding balance under the agreement. The carrying amount of the short-term and long-term debt approximates the estimated fair value.
Note 8. Fair Value Measurements
ASC 820-10, Fair Value Measurements and Disclosures, defines fair value, establishes guidelines and enhances disclosure requirements for fair value measurements. The accounting guidance requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The accounting guidance also establishes a fair value hierarchy based on the independence of the source and objective evidence of the inputs used. There are three fair value hierarchies based upon the level of inputs that are significant to fair value measurement:
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Level 1—Observable inputs that reflect quoted prices (unadjusted) for identical instruments in active markets;
Level 2—Observable inputs other than quoted prices for identical instruments in active markets, quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in inactive markets, and model-driven valuations in which all significant inputs and significant value drivers are observable in active markets; and
Level 3—Unobservable inputs derived from fair valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
On a recurring basis, we measure the fair value of certain assets and liabilities, which include cash equivalents, short-term investments, non-qualified deferred compensation plan assets, and foreign currency derivative contracts.
Our cash equivalents and short-term investments are classified within Level 1 or Level 2 because they are valued using quoted market prices in an active market or alternative independent pricing sources and models utilizing market observable inputs.
Our non-qualified deferred compensation plan assets consist of money market and mutual funds invested in domestic and international marketable securities that are directly observable in active markets and are therefore classified within Level 1.
Our foreign currency derivative contracts are classified within Level 2 because these contracts are not actively traded and the valuation inputs are based on quoted prices and market observable data of similar instruments.
Our borrowings under our Credit and Term Loan facilities are classified within Level 2 because these borrowings are not actively traded and have a variable interest rate structure based upon market rates currently available to us for debt with similar terms and maturities. See Note 7. Financial Assets and Liabilities of the Notes to Consolidated Financial Statements for more information on these borrowings.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Assets/Liabilities Measured at Fair Value on a Recurring Basis
Assets and liabilities measured at fair value on a recurring basis are summarized below as of October 31, 2023:
| | | | | | | | | | | | | | | | | | | | | | | |
| | | Fair Value Measurement Using |
Description | Total | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) |
| (in thousands) |
Assets | | | | | | | |
Cash equivalents: | | | | | | | |
Money market funds | $ | 10,129 | | | $ | 10,129 | | | $ | — | | | $ | — | |
| | | | | | | |
U.S. Treasury, agency & T-bills | 2,994 | | | | | 2,994 | | | — | |
| | | | | | | |
Short-term investments: | | | | | | | |
U.S. Treasury, agency & T-bills | 15,689 | | | — | | | 15,689 | | | — | |
Municipal bonds | 499 | | | — | | | 499 | | | — | |
Corporate debt securities | 102,375 | | | — | | | 102,375 | | | — | |
Asset-backed securities | 33,076 | | | — | | | 33,076 | | | — | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Prepaid and other current assets: | | | | | | | |
Foreign currency derivative contracts | 13,453 | | | — | | | 13,453 | | | — | |
Other long-term assets: | | | | | | | |
Deferred compensation plan assets | 300,731 | | | 300,731 | | | — | | | — | |
Total assets | $ | 478,946 | | | $ | 310,860 | | | $ | 168,086 | | | $ | — | |
Liabilities | | | | | | | |
Accounts payable and accrued liabilities: | | | | | | | |
Foreign currency derivative contracts | $ | 15,761 | | | $ | — | | | $ | 15,761 | | | $ | — | |
Other long-term liabilities: | | | | | | | |
Deferred compensation plan liabilities | 300,731 | | | 300,731 | | | — | | | — | |
Total liabilities | $ | 316,492 | | | $ | 300,731 | | | $ | 15,761 | | | $ | — | |
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Assets and liabilities measured at fair value on a recurring basis are summarized below as of October 31, 2022:
| | | | | | | | | | | | | | | | | | | | | | | |
Description | Total | | Fair Value Measurement Using |
Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) |
| (in thousands) |
Assets | | | | | | | |
Cash equivalents: | | | | | | | |
Money market funds | $ | 77,683 | | | $ | 77,683 | | | $ | — | | | $ | — | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Short-term investments: | | | | | | | |
U.S. Treasury, agency & T-bills | 25,603 | | | — | | | 25,603 | | | — | |
Municipal bonds | 2,878 | | | — | | | 2,878 | | | — | |
Corporate debt securities | 94,024 | | | — | | | 94,024 | | | — | |
Asset-backed securities | 25,408 | | | — | | | 25,408 | | | — | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Prepaid and other current assets: | | | | | | | |
Foreign currency derivative contracts | 2,538 | | | — | | | 2,538 | | | — | |
Other long-term assets: | | | | | | | |
Deferred compensation plan assets | 279,096 | | | 279,096 | | | — | | | — | |
Total assets | $ | 507,230 | | | $ | 356,779 | | | $ | 150,451 | | | $ | — | |
Liabilities | | | | | | | |
Accounts payable and accrued liabilities: | | | | | | | |
Foreign currency derivative contracts | $ | 52,618 | | | $ | — | | | $ | 52,618 | | | $ | — | |
Other long-term liabilities: | | | | | | | |
Deferred compensation plan liabilities | 279,096 | | | 279,096 | | | — | | | — | |
Total liabilities | $ | 331,714 | | | $ | 279,096 | | | $ | 52,618 | | | $ | — | |
Assets/Liabilities Measured at Fair Value on a Non-Recurring Basis
Non-Marketable Equity Securities
Non-marketable equity securities are classified within Level 3 as they are valued using a combination of observable transaction price and unobservable inputs or data in an inactive market due to the absence of market price and inherent lack of liquidity.
Note 9. Leases
We have operating lease arrangements for office space, data center, equipment and other corporate assets. These leases have various expiration dates through December 31, 2042, some of which include options to extend the leases for up to 10 years. Because we are not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term and associated potential option payments are excluded from lease payments.
The components of our lease expense during the period presented are as follows:
| | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 |
| (in thousands) |
Operating lease expense (1) | $ | 96,083 | | | $ | 91,972 | |
| | | |
Variable lease expense (2) | 20,789 | | | 11,649 | |
Total lease expense | $ | 116,872 | | | $ | 103,621 | |
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
(1)Operating lease expense includes immaterial amounts of short-term leases, net of sublease income.
(2)Variable lease expense includes payments to lessors that are not fixed or determinable at lease commencement date. These payments primarily consist of maintenance, property taxes, insurance and variable indexed based payments.
Supplemental cash flow information during the period presented is as follows:
| | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 |
| (in thousands) |
Cash paid for amounts included in the measurement of operating lease liabilities | $ | 88,983 | | | $ | 83,858 | |
ROU assets obtained in exchange for operating lease liabilities | $ | 101,390 | | | $ | 168,095 | |
Lease term and discount rate information related to our operating leases as of the end of the period presented are as follows:
| | | | | | | | | | | |
| As of October 31, |
| 2023 | | 2022 |
Weighted-average remaining lease term (in years) | 8.34 | | 9.16 |
Weighted-average discount rate | 2.50 | % | | 2.19 | % |
The following table represents the maturities of our future lease payments due under operating leases as of October 31, 2023:
| | | | | |
| Lease Payments |
Fiscal year | (in thousands) |
2024 | $ | 102,297 | |
2025 | 102,849 | |
2026 | 92,687 | |
2027 | 91,038 | |
2028 | 77,010 | |
2029 and thereafter | 282,186 | |
Total future minimum lease payments | 748,067 | |
Less: Imputed interest | 78,342 | |
Total lease liabilities | $ | 669,725 | |
In addition, certain facilities owned by us were leased to third parties under non-cancellable operating lease agreements. These leases have annual escalating payments and have expiration dates through March 31, 2031 in accordance with the terms and conditions of the existing agreement. The lease receipts from owned facilities, including sublease income from other facilities leased by us, due to us as of October 31, 2023, are as follows: | | | | | | | | | |
| Lease Receipts | | | | |
| (in thousands) | | | | |
Fiscal year | | | | | |
2024 | $ | 24,698 | | | | | |
2025 | 25,351 | | | | | |
2026 | 26,230 | | | | | |
2027 | 27,376 | | | | | |
2028 | 27,557 | | | | | |
2029 and thereafter | 56,491 | | | | | |
Total | $ | 187,703 | | | | | |
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Note 10. Contingencies
Legal Proceedings
We are subject to routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. The ultimate outcome of any litigation is often uncertain and unfavorable outcomes could have a negative impact on our results of operations and financial condition. We regularly review the status of each significant matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount is estimable, we accrue a liability for the estimated loss. Legal proceedings are inherently uncertain and as circumstances change, it is possible that the amount of any accrued liability may increase, decrease, or be eliminated.
We have determined that, except as set forth below, no disclosure of estimated loss is required for a claim against us because: (1) there is not a reasonable possibility that a loss exceeding amounts already recognized (if any) may be incurred with respect to such claim; (2) a reasonably possible loss or range of loss cannot be estimated; or (3) such estimate is immaterial.
Mentor Patent Litigation
Prior to the legal settlement as further described below, we were engaged in complex patent litigation with Mentor Graphics Corporation (Mentor) involving several actions in different forums. We succeeded to the litigation when we acquired Emulation & Verification Engineering S.A. on October 4, 2012.
Legal Settlement
In March 2017, Siemens PLM Software (Siemens) acquired Mentor. On June 29, 2018, we, Siemens and Mentor settled all outstanding patent litigation between us and Mentor for a $65.0 million payment made from us to Mentor. As a result of the settlement, the litigation with Mentor was dismissed and the injunction entered in connection with that litigation was vacated. The settlement included mutual seven-year patent cross-licenses between us and Siemens, and between us and Mentor. We and Mentor also amended an existing interoperability agreement to collaborate on a wide range of EDA products for the benefit of our mutual customers. The amendment includes a one-time termination charge between $0.0 and $25.0 million, payable to Mentor under certain conditions.
Tax Matters
We undergo examination from time to time by U.S. and foreign authorities for non-income based taxes, such as sales, use and value-added taxes, and are currently under examination by tax authorities in certain jurisdictions. If the potential loss from such examinations is considered probable and the amount or the range of loss could be estimated, we would accrue a liability for the estimated expense. In addition to the foregoing, we are, from time to time, party to various other claims and legal proceedings in the ordinary course of our business, including with tax and other governmental authorities. For a description of certain of these other matters, refer to Note 15. Income Taxes of the Notes to Consolidated Financial Statements.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Note 11. Accumulated Other Comprehensive Income (Loss)
The components of accumulated other comprehensive income (loss), on an after-tax basis where applicable, are as follows:
| | | | | | | | | | | |
| As of October 31, |
| 2023 | | 2022 |
| (in thousands) |
Cumulative currency translation adjustments | $ | (170,104) | | | $ | (156,192) | |
Unrealized gains (losses) on derivative instruments, net of taxes | (25,224) | | | (75,486) | |
Unrealized gains (losses) on available-for-sale securities, net of taxes | (1,086) | | | (2,599) | |
Total | $ | (196,414) | | | $ | (234,277) | |
The effect of amounts reclassified out of each component of accumulated other comprehensive income (loss) into net income is as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
| (in thousands) |
Reclassifications: | | | | | |
Gains (losses) on cash flow hedges, net of taxes | | | | | |
Revenues | $ | (9,942) | | | $ | 10,975 | | | $ | 4,181 | |
Operating expenses | (15,334) | | | (15,869) | | | 10,378 | |
| | | | | |
| | | | | |
Total | $ | (25,276) | | | $ | (4,894) | | | $ | 14,559 | |
Amounts reclassified in fiscal 2023, 2022, and 2021 primarily consisted of gains (losses) from our cash flow hedging activities. See Note 7. Financial Assets and Liabilities of the Notes to Consolidated Financial Statements.
Note 12. Stock Repurchase Program
In fiscal 2022, our Board of Directors approved a stock repurchase program (the Program) with authorization to purchase up to $1.5 billion of our common stock. As of October 31, 2023, $194.3 million remained available for future repurchases under the Program.
In August 2023, we entered into an accelerated stock repurchase agreement (the August 2023 ASR) to repurchase an aggregate of $300.0 million of our common stock. Pursuant to the August 2023 ASR, we made a prepayment of $300.0 million to receive initial deliveries of shares valued at $255.0 million. The remaining balance of $45.0 million was settled in November 2023. Total shares purchased under the August 2023 ASR were approximately 0.6 million shares, at an average purchase price of $466.71 per share.
Stock repurchase activities as well as the reissuance of treasury stock for employee stock-based compensation purposes are as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 (1) | | 2022 | | 2021 (2) |
| (in thousands, except per share price) |
Shares repurchased | 2,992 | | | 3,609 | | | 2,780 | |
Average purchase price per share | $ | 387.92 | | | $ | 314.51 | | | $ | 270.84 | |
Aggregate purchase price | $ | 1,160,724 | | | $ | 1,135,000 | | | $ | 753,081 | |
Reissuance of treasury stock | 2,670 | | | 2,922 | | | 3,224 | |
(1) Excludes 73,903 shares and $45.0 million equity forward contract that was settled in November 2023.
(2) Excludes 107,701 shares and $35.0 million equity forward contract that was settled in November 2021.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Note 13. Employee Benefit Plans
Employee Stock Purchase Plan
Under our Employee Stock Purchase Plan (ESPP), participating employees are granted the right to purchase shares of common stock at a price per share that is 85% of the lesser of the fair market value of the shares at (1) the beginning of an offering period (generally, a rolling two year period) or (2) the purchase date (generally occurring at the end of each semi-annual purchase period), subject to the terms of ESPP, including a limit on the number of shares that may be purchased in a purchase period.
On April 12, 2022, our stockholders approved amendments to the ESPP to increase the number of shares of common stock authorized for issuance under the plan by 2.0 million shares. During fiscal 2023, 2022 and 2021, we issued 0.6 million, 0.7 million, and 1.0 million shares, respectively, under the ESPP at average per share prices of $266.82, $195.48 and $134.26, respectively. As of October 31, 2023, 13.5 million shares of common stock were reserved for future issuance under the ESPP.
Equity Compensation Plans
2006 Employee Equity Incentive Plan. On April 25, 2006, our stockholders approved the 2006 Employee Equity Incentive Plan (2006 Employee Plan), which provides for the grant of incentive stock options, non-statutory stock options, restricted stock awards, restricted stock unit awards, stock appreciation rights and other forms of equity compensation, including performance stock awards and performance cash awards, as determined by the plan administrator. The terms and conditions of each type of award are set forth in the 2006 Employee Plan and in the award agreements governing particular awards.
Restricted stock units are granted under the 2006 Employee Plan as part of our incentive compensation program. In general, restricted stock units vest over three to four years and are subject to the employee's continuing service with us. Restricted stock units granted with specific performance criteria vest to the extent performance conditions are met. Restricted stock units granted with certain market conditions vest over two to three years to the extent these market conditions are met. For each restricted stock unit granted under the 2006 Employee Plan, a share reserve ratio of 1.70 is applied for the purpose of determining the remaining number of shares reserved for future grants under the plan. Options granted under this plan generally have a contractual term of seven years and generally vest over four years.
On April 12, 2023, our stockholders amended the 2006 Employee Plan to, among other things, increase the number of shares of common stock reserved for future issuance under the plan by 3.3 million shares. As of October 31, 2023, an aggregate of 1.5 million stock options and 4.5 million restricted stock units were outstanding, and 13.3 million shares were available for future issuance under the 2006 Employee Plan.
2005 and 2017 Non-Employee Directors Equity Incentive Plans. On April 6, 2017, our stockholders approved the 2017 Non-Employee Directors Equity Incentive Plan (2017 Directors Plan). In connection with stockholder approval of the 2017 Directors Plan, the 2005 Non-Employee Directors Equity Incentive Plan (2005 Directors Plan) was terminated as of April 6, 2017, and no awards could be granted under the 2005 Directors Plan after that date.
Under the 2005 Directors Plan, we granted options, which vest over a period of three to four years to non-employee directors. As of October 31, 2023, 7,500 stock options were outstanding under the 2005 Directors Plan.
The 2017 Directors Plan provides for equity awards to non-employee directors in the form of stock options, restricted stock units, restricted stock or a combination thereof. On April 6, 2017, our stockholders approved an aggregate of 0.45 million shares of common stock reserved under the 2017 Directors Plan.
We grant restricted stock awards and options under the 2017 Directors Plan. Restricted stock awards generally vest on an annual basis and options vest over a period of three years. As of October 31, 2023, 4,806 shares of restricted stock awards were unvested and 12,792 stock options were outstanding, and a total of 368,407 shares of common stock were reserved for future issuance under the 2017 Directors Plan.
Other Assumed Stock Plans through Acquisitions. We have assumed certain outstanding stock awards of acquired companies, including restricted stock units and options. If these assumed equity awards are canceled, forfeited or expire unexercised, the underlying shares do not become available for future grant. As of October 31, 2023, 31 thousand shares of our common stock remained subject to such outstanding assumed equity awards.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Restricted Stock Units. The following table contains information concerning activities related to restricted stock units granted under the 2006 Employee Plan and assumed from acquisitions:
| | | | | | | | | | | | | | | | | | | | | | | |
| Restricted Stock Units Outstanding(1) | | Weighted Average Grant Date Fair Value | | Weighted Average Remaining Contractual Life (In Years) | | Aggregate Fair Value |
| (in thousands, except per share amounts and years) |
Balance at October 31, 2020 | 4,130 | | | $ | 134.80 | | | 1.47 | | |
Granted(2) | 1,901 | | | $ | 258.58 | | | | | |
Vested(4) | (1,565) | | | $ | 122.01 | | | | | $ | 421,034 | |
Forfeited | (279) | | | $ | 167.76 | | | | | |
Balance at October 31, 2021 | 4,187 | | | $ | 193.58 | | | 1.39 | | |
Granted(3) | 2,402 | | | $ | 323.46 | | | | | |
Vested(4) | (1,589) | | | $ | 170.36 | | | | | $ | 529,766 | |
Forfeited | (362) | | | $ | 228.70 | | | | | |
Balance at October 31, 2022 | 4,638 | | | $ | 265.76 | | | 1.32 | | |
Granted(3) | 2,083 | | | $ | 394.34 | | | | | |
Vested(4) | (1,839) | | | $ | 237.19 | | | | | $ | 706,136 | |
Forfeited | (365) | | | $ | 283.29 | | | | | |
Balance at October 31, 2023 | 4,517 | | | $ | 335.26 | | | 1.41 | | |
(1)No restricted stock units were assumed in connection with acquisitions in the last three fiscal years, but the balance at fiscal year-end includes certain restricted stock units that were previously assumed in connection with acquisitions.
(2)The number of granted restricted stock units includes those granted to senior management with performance-based vesting criteria (in addition to service-based vesting criteria) (performance-based RSUs) reported at the maximum possible number of shares that may ultimately be issuable if all applicable performance-based criteria are achieved at their maximum levels and all applicable service-based criteria are fully satisfied.
(3)The number of granted restricted stock units includes those granted to senior management with market-based and performance-based vesting criteria (in addition to service-based vesting criteria) (market-based RSUs) reported at the maximum possible number of shares that may ultimately be issuable if all applicable market-based and performance-based criteria are achieved at their maximum levels and all applicable service-based criteria are fully satisfied.
(4)The number of vested restricted stock units includes shares that were withheld on behalf of employees to satisfy the minimum statutory tax withholding requirements.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Stock Options. The following table summarizes stock option activity and includes stock options granted under all equity plans:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Options Outstanding | | | | |
| Shares Under Stock Option (1) | | Weighted- Average Exercise Price per Share | | Weighted- Average Remaining Contractual Life (In Years) | | Aggregate Intrinsic Value | | | | |
| | (in thousands, except per share amounts and years) | | | | |
Balance at October 31, 2020 | | 3,993 | | | $ | 85.26 | | | 4.10 | | $ | 513,845 | | | | | |
Granted | | 353 | | | $ | 239.46 | | | | | | | | | |
| | | | | | | | | | | | |
Exercised | | (1,203) | | | $ | 66.50 | | | | | | | | | |
Canceled/forfeited/expired | | (36) | | | $ | 128.49 | | | | | | | | | |
Balance at October 31, 2021 | | 3,107 | | | $ | 109.51 | | | 3.81 | | $ | 694,921 | | | | | |
Granted | | 293 | | | $ | 342.86 | | | | | | | | | |
| | | | | | | | | | | | |
Exercised | | (1,126) | | | $ | 86.24 | | | | | | | | | |
Canceled/forfeited/expired | | (114) | | | $ | 164.46 | | | | | | | | | |
Balance at October 31, 2022 | | 2,160 | | | $ | 150.37 | | | 3.57 | | $ | 328,120 | | | | | |
Granted | | 294 | | | $ | 361.64 | | | | | | | | | |
| | | | | | | | | | | | |
Exercised | | (849) | | | $ | 109.83 | | | | | | | | | |
Canceled/forfeited/expired | | (90) | | | $ | 245.86 | | | | | | | | | |
Balance at October 31, 2023 | | 1,515 | | | $ | 208.49 | | | 3.70 | | $ | 376,563 | | | | | |
Vested and expected to vest as of October 31, 2023 | | 1,515 | | | $ | 208.49 | | | 3.70 | | $ | 376,563 | | | | | |
Exercisable at October 31, 2023 | | 972 | | | $ | 142.41 | | | 2.67 | | $ | 305,738 | | | | | |
(1)No stock options were assumed in connection with acquisitions in the last three fiscal years, but the balance at fiscal year-end includes certain stock options that were previously assumed in connection with acquisitions.
The aggregate intrinsic value in the preceding table represents the pre-tax intrinsic value based on stock options with an exercise price less than our closing stock price of $457.00 as of October 31, 2023. The pre-tax intrinsic value of options exercised and their average exercise prices are:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
| (in thousands, except per share price) |
Intrinsic value | $ | 241,385 | | | $ | 273,524 | | | $ | 254,587 | |
Average exercise price per share | $ | 109.83 | | | $ | 86.24 | | | $ | 66.50 | |
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Restricted Stock Units and Stock Options. The following table contains additional information concerning activities related to stock options and restricted stock units that were granted under the 2006 Employee Plan and assumed from acquisitions:
| | | | | | | | | | | | | |
| Available for Grant (1)(2) | | |
| | | | | | | |
| (in thousands) |
Balance at October 31, 2020 | 12,129 | | | | | | | | | |
Options granted(2) | (353) | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Options canceled/forfeited/expired(2) | 36 | | | | | | | | | |
Restricted stock units granted(1)(3) | (3,232) | | | | | | | | | |
Restricted stock units forfeited(1) | 471 | | | | | | | | | |
Additional shares reserved | 4,700 | | | | | | | | | |
Balance at October 31, 2021 | 13,751 | | | | | | | | | |
Options granted(2) | (286) | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Options canceled/forfeited/expired(2) | 114 | | | | | | | | | |
Restricted stock units granted(1)(4) | (4,083) | | | | | | | | | |
Restricted stock units forfeited(1) | 615 | | | | | | | | | |
Additional shares reserved | 3,000 | | | | | | | | | |
Balance at October 31, 2022 | 13,111 | | | | | | | | | |
Options granted(2) | (294) | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Options canceled/forfeited/expired(2) | 89 | | | | | | | | | |
Restricted stock units granted(1)(4) | (3,540) | | | | | | | | | |
Restricted stock units forfeited(1) | 620 | | | | | | | | | |
Additional shares reserved | 3,300 | | | | | | | | | |
Balance at October 31, 2023 | 13,286 | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
(1)Restricted stock units includes awards granted under the 2006 Employee Plan and assumed through acquisitions. The number of RSUs reflects the application of the award multiplier of 1.70 as described above.
(2)Options granted by us are not subject to the award multiplier ratio described above.
(3)The number of granted restricted stock units includes performance-based RSUs reported at the maximum possible number of shares that may ultimately be issuable if all applicable performance-based criteria are achieved at their maximum levels and all applicable service-based criteria are fully satisfied.
(4)The number of granted restricted stock units includes market-based RSUs reported at the maximum possible number of shares that may ultimately be issuable if all applicable market-based and performance-based criteria are achieved at their maximum levels and all applicable service-based criteria are fully satisfied.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Restricted Stock Awards. The following table summarizes restricted stock award activities under the 2005 Directors Plan and 2017 Directors Plan:
| | | | | | | | | | | |
| Restricted Shares | | Weighted-Average Grant Date Fair Value |
| (in thousands, except per share amounts) |
Unvested at October 31, 2020 | 9 | | | $ | 140.97 | |
Granted | 5 | | | $ | 261.01 | |
Vested | (9) | | | $ | 140.97 | |
Forfeited | — | | | $ | — | |
Unvested at October 31, 2021 | 5 | | | $ | 261.01 | |
Granted | 5 | | | $ | 310.02 | |
Vested | (5) | | | $ | 261.01 | |
Forfeited | — | | | $ | — | |
Unvested at October 31, 2022 | 5 | | | $ | 310.02 | |
Granted | 5 | | | $ | 387.79 | |
Vested | (5) | | | $ | 310.02 | |
Forfeited | — | | | $ | — | |
Unvested at October 31, 2023 | 5 | | | $ | 387.79 | |
Valuation and Expense of Stock-Based Compensation. We estimate the fair value of stock options and employee stock purchase rights under the ESPP on the grant date. The value of awards expected to vest is recognized as expense over the applicable service periods. We use the Black-Scholes option-pricing model to determine the fair value of stock options and employee stock purchase plan rights. The Black-Scholes option-pricing model incorporates various assumptions including expected volatility, expected term and interest rates. The expected volatility for both stock options and employee stock purchase rights is estimated by a combination of implied volatility for publicly traded options of our common stock with a term of six months or longer and the historical stock price volatility over the estimated expected term of such awards, which is based on historical experience.
Restricted stock units are valued based on the closing price of our common stock on the grant date. We use the straight-line attribution method to recognize stock-based compensation costs over the service period of the award except for performance-based RSUs and market-based RSUs.
We estimate the probability of achievement of applicable performance goals for performance-based RSUs in each reporting period and recognize related stock-based compensation expense using the graded-vesting method. The amount of stock-based compensation expense recognized in any period can vary based on the attainment or expected attainment of the various performance goals. If such performance goals are not ultimately met, no compensation expense is recognized and any previously recognized compensation expense is reversed.
We estimated the fair value of market-based RSUs on the grant date using a Monte Carlo simulation model. Under the award agreements, the vesting of the market-based RSUs is contingent on achieving total stockholder return (TSR) relative to a peer index as well as revenue growth metrics. The maximum potential awards that may be earned are 187.5% of the target number of the initial awards. For market-based RSUs granted in February, May, August and December 2022, the performance period during which the achievement goals will be measured is fiscal 2022 and fiscal 2023. The awards will vest in equal increments in December 2023 and December 2024 if the TSR target, revenue growth metrics, and service conditions are achieved. For market-based RSUs granted in February and August 2023, the performance period during which the achievement goals will be measured is fiscal 2023, fiscal 2024 and fiscal 2025. The awards will vest in December 2025 if the TSR target, revenue growth metrics, and service conditions are achieved.
The assumptions presented in the following table are used to estimate the fair value of stock options and employee stock purchase rights granted under our stock plans:
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
Stock Options: | | | | | |
Expected life (in years) | 4.1 | | 4.1 | | 4.1 |
Risk-free interest rate | 3.80%- 4.80% | | 1.07% - 4.42% | | 0.35% - 1.00% |
Volatility | 32.74% -36.16% | | 32.28% - 37.04% | | 29.19%- 32.28% |
Weighted average estimated fair value | $120.33 | | $98.07 | | $61.58 |
ESPP: | | | | | |
Expected life (in years) | 0.5 - 2.0 | | 0.5 - 2.0 | | 0.5 - 2.0 |
Risk-free interest rate | 4.85% - 5.38% | | 0.67% - 3.44% | | 0.00% - 0.19% |
Volatility | 28.03% - 35.27% | | 34.51% - 38.69% | | 28.02% - 39.68% |
Weighted average estimated fair value | $120.82 | | $102.63 | | $89.82 |
The grant date fair value of the market-based RSUs and the assumptions used in the Monte Carlo simulation model to determine the grant date fair value during the periods are as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021(1) |
Expected life (in years) | 0.90 - 2.70 | | 1.16 - 1.69 | | — |
Risk-free interest rate | 4.36% - 4.80% | | 1.33% - 3.46% | | — |
Volatility | 34.79% - 42.86% | | 33.01% - 37.80% | | — |
Grant date fair value | $357.29 - $465.79 | | $280.52 - $412.2 | | — |
(1) No market-based RSUs were granted in fiscal 2021.
The compensation cost recognized in the consolidated statements of income for our stock compensation arrangements is as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
| (in thousands) |
Cost of products | $ | 65,221 | | | $ | 55,134 | | | $ | 38,345 | |
Cost of maintenance and service | 29,572 | | | 24,146 | | | 13,817 | |
Research and development expense | 294,154 | | | 241,978 | | | 171,013 | |
Sales and marketing expense | 106,574 | | | 81,617 | | | 61,940 | |
General and administrative expense | 67,771 | | | 56,154 | | | 60,157 | |
Stock-based compensation expense before taxes | 563,292 | | | 459,029 | | | 345,272 | |
Income tax benefit | (90,915) | | | (74,271) | | | (53,483) | |
Stock-based compensation expense after taxes | $ | 472,377 | | | $ | 384,758 | | | $ | 291,789 | |
As of October 31, 2023, we had $1.2 billion of total unrecognized stock-based compensation expense relating to options, RSUs and restricted stock awards, which is expected to be recognized over a weighted average period of 1.7 years. As of October 31, 2023, we had $42.3 million of total unrecognized stock-based compensation expense relating to the ESPP, which is expected to be recognized over a period of 2.0 years.
Deferred Compensation Plan. We maintain the Synopsys Deferred Compensation Plan (Deferred Plan), which permits eligible employees to defer up to 50% of their annual cash base compensation and up to 100% of their eligible cash variable compensation. Amounts may be withdrawn from the Deferred Plan pursuant to elections made by the employees in accordance with the terms of the plan. Since the inception of the Deferred Plan, we have not made any matching or discretionary contributions to the Deferred Plan. There are no Deferred Plan provisions that
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
provide for any guarantees or minimum return on investments. Undistributed amounts under the Deferred Plan are subject to the claims of our creditors.
Deferred plan assets and liabilities are as follows:
| | | | | | | | | | | |
| As of October 31, |
| 2023 | | 2022 |
| (in thousands) |
Plan assets recorded in other long-term assets | $ | 300,731 | | | $ | 279,096 | |
Plan liabilities recorded in other long-term liabilities(1) | $ | 300,731 | | | $ | 279,096 | |
(1)Undistributed deferred compensation balances due to participants.
Income or loss from the change in fair value of the Deferred Plan assets is recorded in other income (expense), net. The increase or decrease in the fair value of the undistributed Deferred Plan obligation is recorded in total cost of revenue and operating expense. The following table summarizes the impact of the Deferred Plan:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
| (in thousands) |
Increase (reduction) to cost of revenue and operating expense | $ | 20,488 | | | $ | (68,778) | | | $ | 71,603 | |
Other income (expense), net | 20,488 | | | (68,778) | | | 71,603 | |
Net increase (decrease) to net income | $ | — | | | $ | — | | | $ | — | |
Other Retirement Plans. We sponsor various defined contribution retirement plans for our eligible U.S. and non-U.S. employees. Total contributions to these plans were $59.2 million, $51.2 million, and $49.4 million in fiscal 2023, 2022, and 2021, respectively. For employees in the United States and Canada, we match pre-tax employee contributions up to a maximum of U.S. $3,000 and Canadian $4,000, respectively, per participant per year.
Certain of our international subsidiaries sponsor defined benefit retirement plans. The unfunded projected benefit obligation for these defined benefit retirement plans as of October 31, 2023 and 2022 was immaterial and recorded in other long-term liabilities in our consolidated balance sheets.
Note 14. Net Income Per Share
The table below reconciles the weighted average common shares used to calculate basic net income per share with the weighted average common shares used to calculate diluted net income per share:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
| (in thousands, except per share amounts) |
Numerator: | | | | | |
Net income attributed to Synopsys | $ | 1,229,888 | | | $ | 984,594 | | | $ | 757,516 | |
Denominator: | | | | | |
Weighted average common shares for basic net income per share | 152,146 | | | 153,002 | | | 152,698 | |
Dilutive effect of common share equivalents from equity-based compensation | 3,049 | | | 3,483 | | | 4,642 | |
Weighted average common shares for diluted net income per share | 155,195 | | | 156,485 | | | 157,340 | |
Net income per share attributed to Synopsys: | | | | | |
Basic | $ | 8.08 | | | $ | 6.44 | | | $ | 4.96 | |
Diluted | $ | 7.92 | | | $ | 6.29 | | | $ | 4.81 | |
Anti-dilutive employee stock-based awards excluded | 475 | | | 281 | | | 408 | |
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Note 15. Income Taxes
The domestic and foreign components of our total income (loss) before provision for income taxes are as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
| (in thousands) |
United States | $ | 1,142,132 | | | $ | 1,036,279 | | | $ | 640,531 | |
Foreign | 159,650 | | | 79,235 | | | 164,983 | |
Total income (loss) before provision for income taxes | $ | 1,301,782 | | | $ | 1,115,514 | | | $ | 805,514 | |
The components of the provision (benefit) for income taxes are as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
| (in thousands) |
Current: | | | | | |
Federal | $ | 244,523 | | | $ | 105,493 | | | $ | 85,950 | |
State | 22,193 | | | 23,201 | | | 11,898 | |
Foreign | 27,986 | | | 45,297 | | | 79,890 | |
| 294,702 | | | 173,991 | | | 177,738 | |
Deferred: | | | | | |
Federal | (192,762) | | | (42,086) | | | (108,530) | |
State | (1,842) | | | 1,519 | | | 1,796 | |
Foreign | (16,441) | | | 3,654 | | | (21,849) | |
| (211,045) | | | (36,913) | | | (128,583) | |
Provision (benefit) for income taxes | $ | 83,657 | | | $ | 137,078 | | | $ | 49,155 | |
The provision (benefit) for income taxes differs from the taxes computed with the statutory federal income tax rate as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
| (in thousands) |
Statutory federal tax | $ | 273,374 | | | $ | 234,257 | | | $ | 168,745 | |
State tax (benefit), net of federal effect | 617 | | | (2,514) | | | (2,419) | |
Federal tax credits | (65,878) | | | (61,582) | | | (45,503) | |
Tax (benefit) on foreign earnings | (12,454) | | | 25,930 | | | 7,988 | |
Foreign-derived intangible income deduction | (82,436) | | | (38,924) | | | (31,214) | |
Tax settlements | (23,752) | | | — | | | (7,134) | |
Stock-based compensation | (43,153) | | | (52,625) | | | (62,620) | |
Changes in valuation allowance | 29,631 | | | 19,794 | | | 15,232 | |
| | | | | |
Other | 7,708 | | | 12,742 | | | 6,080 | |
Provision (benefit) for income taxes | $ | 83,657 | | | $ | 137,078 | | | $ | 49,155 | |
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
On December 22, 2017, the Tax Cuts and Jobs Act (Tax Act) was enacted, which significantly changed prior U.S. tax law and includes numerous provisions that affect our business. Effective in our fiscal 2023 year, the Tax Act requires that research and development expenditures are capitalized and amortized instead of being deducted when incurred. Domestic research is capitalized over five years and foreign research is capitalized over fifteen years. For fiscal 2023, this resulted in a significant increase to our current cash tax liabilities; however, the tax payment deadline was extended until November 16, 2023, due to IRS tax relief for the California winter storms. Capitalization of research and development expenditures also results in a corresponding deferred tax benefit and decreased our effective tax rate due to increasing the foreign-derived intangible income deduction.
We have provided for foreign withholding taxes on undistributed earnings of certain of our foreign subsidiaries to the extent such earnings are no longer considered to be indefinitely reinvested in the operations of those subsidiaries. Where foreign subsidiaries are considered indefinitely reinvested, and if the tax effect of undistributed earnings and other outside basis differences were recognized, the nature of taxes expected would be primarily be withholding taxes, taxes in non-conforming states, and taxes on intermediate holding companies outside of the U.S., net of foreign tax credits where available. As of October 31, 2023, the taxes due, after allowable foreign tax credits, are not expected to be material.
The significant components of deferred tax assets and liabilities are as follows:
| | | | | | | | | | | |
| As of October 31, |
| 2023 | | 2022 |
| (in thousands) |
Net deferred tax assets: | | | |
Deferred tax assets: | | | |
Deferred revenue | 37,641 | | | 41,941 | |
Deferred compensation | 69,824 | | | 67,782 | |
Intangible and depreciable assets | 94,564 | | | 119,791 | |
Capitalized research and development costs | 592,536 | | | 231,733 | |
Stock-based compensation | 65,039 | | | 60,537 | |
Tax loss carryovers | 62,779 | | | 59,754 | |
Foreign tax credit carryovers | 41,972 | | | 27,153 | |
Research and other tax credit carryovers | 182,999 | | | 316,650 | |
Operating Lease Liabilities | 118,679 | | | 119,575 | |
Accruals and reserves | 27,636 | | | — | |
Other | — | | | 16,887 | |
Gross deferred tax assets | 1,293,669 | | | 1,061,803 | |
Valuation allowance | (229,259) | | | (198,213) | |
Total deferred tax assets | 1,064,410 | | | 863,590 | |
Deferred tax liabilities: | | | |
Intangible assets | 116,465 | | | 102,796 | |
Operating lease Right-of-Use-Assets | 94,068 | | | 96,598 | |
Accruals and reserves | — | | | 5,998 | |
Undistributed earnings of foreign subsidiaries | 8,900 | | | 1,000 | |
Other | 18,006 | | | — | |
Total deferred tax liabilities | 237,439 | | | 206,392 | |
Net deferred tax assets | $ | 826,971 | | | $ | 657,198 | |
It is more likely than not that the results of future operations will be able to generate sufficient taxable income to realize the net deferred tax assets. The valuation allowance provided against our deferred tax assets as of October 31, 2023 is mainly attributable to foreign tax credits available to non-U.S. subsidiaries and the California research credits. The valuation allowance increased by a net of $31.0 million in fiscal 2023 primarily related to the net increase of valuation allowance on California research credits.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
We have the following tax loss and credit carryforwards available to offset future income tax liabilities:
| | | | | | | | | | | |
Carryforward | Amount | | Expiration Date |
| (in thousands) | | |
Federal net operating loss carryforward | $ | 156,991 | | | 2024-2042 |
Federal research credit carryforward | 14,705 | | | 2024-2038 |
Federal foreign tax credit carryforward | 27,522 | | | 2027-2033 |
International foreign tax credit carryforward | 10,929 | | | Indefinite |
International net operating loss carryforward | 48,823 | | | 2027-Indefinite |
California research credit carryforward | 243,960 | | | Indefinite |
Other state research credit carryforward | 25,176 | | | 2025-2043 |
State net operating loss carryforward | 236,391 | | | 2024-2045 |
The federal and state net operating loss carryforward is from acquired companies and the annual use of such loss is subject to significant limitations under Internal Revenue Code Section 382 and certain provisions of the Tax Act. Foreign tax credits may only be used to offset tax attributable to foreign source income.
The gross unrecognized tax benefits decreased by approximately $6.8 million during fiscal 2023 resulting in gross unrecognized tax benefits of $74.4 million as of October 31, 2023. A reconciliation of the beginning and ending balance of gross unrecognized tax benefits is summarized as follows:
| | | | | | | | | | | |
| As of October 31, |
| 2023 | | 2022 |
| (in thousands) |
Beginning balance | $ | 81,183 | | | $ | 82,360 | |
Increases in unrecognized tax benefits related to prior year tax positions | 211 | | | 435 | |
Decreases in unrecognized tax benefits related to prior year tax positions | (25,678) | | | (9,791) | |
Increases in unrecognized tax benefits related to current year tax positions | 8,223 | | | 6,794 | |
Decreases in unrecognized tax benefits related to settlements with taxing authorities | — | | | (1,104) | |
Reductions in unrecognized tax benefits due to lapse of applicable statute of limitations | (249) | | | (2,601) | |
Increases in unrecognized tax benefits acquired | 165 | | | 14,121 | |
Changes in unrecognized tax benefits due to foreign currency translation | 10,504 | | | (9,031) | |
Ending balance | $ | 74,359 | | | $ | 81,183 | |
As of October 31, 2023 and 2022, approximately $74.4 million and $81.2 million, respectively, of the unrecognized tax benefits would affect our effective tax rate if recognized upon resolution of the uncertain tax positions.
Interest and penalties related to estimated obligations for tax positions taken in our tax returns are recognized as a component of income tax expense (benefit) in the consolidated statements of income and totaled approximately $(10.6) million, $0.8 million and $0.4 million for fiscal years 2023, 2022 and 2021, respectively. As of October 31, 2023 and 2022, the combined amount of accrued interest and penalties related to tax positions taken on our tax returns were approximately $2.1 million and $12.7 million, respectively.
The timing of the resolution of income tax examinations, and the amounts and timing of various tax payments that are part of the settlement process, are highly uncertain. Variations in such amounts and/or timing could cause large fluctuations in the balance sheet classification of current and non-current assets and liabilities. We believe that in the coming 12 months, it is reasonably possible that either certain audits and ongoing tax litigation will conclude or the statute of limitations on certain state and foreign income and withholding taxes will expire, or both. Given the uncertainty as to ultimate settlement terms, the timing of payment and the impact of such settlements on other uncertain tax positions, the range of the estimated potential decrease in underlying unrecognized tax benefits is between $0.0 and $10.0 million.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
We and/or our subsidiaries remain subject to tax examination in the following jurisdictions:
| | | | | |
| |
Jurisdiction | Year(s) Subject to Examination |
United States | Fiscal years after 2020 |
California | Fiscal years after 2018 |
Hungary | Fiscal years after 2018 |
Ireland | Fiscal years after 2018 |
Japan | Fiscal years after 2017 |
Korea and Taiwan | Fiscal years after 2021 |
China | Fiscal years after 2013 |
India | Fiscal years after 2019 |
In addition, we have made acquisitions with operations in several of our significant jurisdictions which may have years subject to examination different from the years indicated in the above table.
IRS Examinations
In fiscal 2021, the Examination Division of the IRS completed its pre-filing review for fiscal 2020 and as a result we recognized approximately $7.1 million in unrecognized tax benefits, primarily due to the allowance of research tax credits.
Non-U.S. Examinations
Hungarian Tax Authority
In 2017, the Hungarian Tax Authority (the HTA) assessed withholding taxes of approximately $25.0 million and interest and penalties of $11.0 million, against our Hungary subsidiary (Synopsys Hungary). Synopsys Hungary contested the assessment with the Hungarian Administrative Court (Administrative Court). In 2019, as required under Hungarian law, Synopsys Hungary paid the assessment and recorded a tax expense due to an unrecognized tax benefit of $17.4 million, which is net of estimated U.S. foreign tax credits. During 2021 and 2022 a series of appeals, hearings and re-hearings occurred at the Administrative Court and Hungarian Supreme Court. Hearings with the Administrative Court were held on June 30, 2022, September 22, 2022 and April 25, 2023. The Administrative Court issued its written decision in favor of Synopsys Hungary on May 17, 2023, and subsequently refunded Synopsys Hungary the tax, penalty and interest paid in fiscal 2018, as well as additional interest all totaling $39.1 million (including the effect of currency movement). The refunded tax, penalty and interest was recognized as an income tax benefit. The HTA had until July 14, 2023, to file an appeal with the Hungarian Supreme Court and the HTA did not appeal. This concludes the litigation. During the third quarter of fiscal 2023, Synopsys released its unrecognized tax benefit and offsetting U.S. foreign tax credits, resulting in a net benefit of $23.8 million.
We are also under examination by the tax authorities in certain other jurisdictions. No material assessments have been proposed in these examinations.
Legislative Developments
On August 16, 2022, the Inflation Reduction Act of 2022 (the IR Act) was enacted in the United States. The IR Act includes a 15% minimum tax based primarily on global consolidated U.S. GAAP profits with a $1 billion minimum threshold. The tax takes effect in fiscal 2024, with the $1 billion threshold measured as an average over three years commencing in the current fiscal year. Computation of the tax includes adjustments which, among others, provide for an offset of income taxes paid or accrued in non-U.S. jurisdictions. The details of the computation will be subject to regulations to be issued by the U.S. Department of the Treasury. Synopsys will monitor regulatory developments and will continue to evaluate the impact, if any, of the minimum tax.
The IR Act imposes a 1% excise tax on the fair market value of stock repurchases made by covered corporations after December 31, 2022. The total taxable value of shares repurchased is reduced by the fair market value of any newly issued shares during the taxable year. As of October 31, 2023, this does not have any impact on our consolidated financial statements.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
On August 9, 2022, the CHIPS and Science Act of 2022 (the CHIPS Act) was enacted in the United States. The CHIPS Act provides financial incentives to the semiconductor industry which are primarily directed at manufacturing activities within the United States. We are evaluating potential opportunities related to the CHIPS Act.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Note 16. Other Income (Expense), Net
The following table presents the components of other income (expense), net:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
| (in thousands) |
Interest income | $ | 36,674 | | | $ | 8,545 | | | $ | 2,442 | |
Interest expense | (1,178) | | | (1,698) | | | (3,365) | |
Gains (losses) on assets related to deferred compensation plan | 20,488 | | | (68,778) | | | 71,603 | |
Foreign currency exchange gains (losses) | (1,529) | | | 4,694 | | | 5,292 | |
Other, net | (21,932) | | | 10,713 | | | (5,248) | |
Total | $ | 32,523 | | | $ | (46,524) | | | $ | 70,724 | |
Note 17. Segment Disclosure
Segment reporting is based upon the “management approach,” i.e., how management organizes our operating segments for which separate financial information is (1) available and (2) evaluated regularly by the CODM in deciding how to allocate resources and in assessing performance. Our CODM is our CEO.
As described in Note 2. Summary of Significant Accounting Policies and Basis of Presentation of the Notes to Consolidated Financial Statements, effective in the first quarter of fiscal 2023, we realigned our organizational structure to evaluate the results of our Design IP business separately. Our CODM now regularly reviews disaggregated segment information, assesses performance against our key growth strategies and allocates resources based on this new organizational structure.
As a result, effective in the first quarter of fiscal 2023, we changed our reportable segments from two reportable segments to the following three reportable segments: (1) Design Automation, which includes our advanced silicon design, verification products and services, system integration products and services, digital, custom and FPGA IC design software, verification software and hardware products, manufacturing software products and other; (2) Design IP, which includes our Design IP products; and (3) Software Integrity, which includes solutions that test software code for security vulnerabilities and quality defects, as well as professional and managed services. As such, prior period reportable segment results and related disclosures have been reclassified to reflect our current reportable segments.
The financial information provided to and used by the CODM to assist in making operational decisions, allocating resources, and assessing performance includes consolidated financial information as well as revenue, adjusted operating income, and adjusted operating margin information for the Design Automation, Design IP and Software Integrity segments, accompanied by disaggregated information relating to revenue by geographic region.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Information by reportable segment is as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
| (in thousands) |
Total Segments: | | | | | |
Revenue | $ | 5,842,619 | | | $ | 5,081,542 | | | $ | 4,204,193 | |
Adjusted operating income | 2,048,045 | | | 1,675,102 | | | 1,281,389 | |
Adjusted operating margin | 35 | % | | 33 | % | | 30 | % |
Design Automation: | | | | | |
Revenue | $ | 3,775,287 | | | $ | 3,300,173 | | | $ | 2,754,737 | |
Adjusted operating income | 1,439,666 | | | 1,206,561 | | | 924,605 | |
Adjusted operating margin | 38 | % | | 37 | % | | 34 | % |
Design IP: | | | | | |
Revenue | $ | 1,542,726 | | | $ | 1,315,541 | | | $ | 1,055,672 | |
Adjusted operating income | 532,055 | | | 421,547 | | | 318,473 | |
Adjusted operating margin | 34 | % | | 32 | % | | 30 | % |
Software Integrity: | | | | | |
Revenue | $ | 524,606 | | | $ | 465,828 | | | $ | 393,784 | |
Adjusted operating income | 76,324 | | | 46,994 | | | 38,311 | |
Adjusted operating margin | 15 | % | | 10 | % | | 10 | % |
Certain operating expenses are not allocated to the segments and are managed at a consolidated level. The unallocated expenses managed at a consolidated level, including amortization of intangible assets, stock-based compensation, changes in the fair value of deferred compensation plan, restructuring charges, and certain other operating expenses, are presented in the table below to provide a reconciliation of the total adjusted operating income from segments to our consolidated operating income:
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
| (in thousands) |
Total segment adjusted operating income | $ | 2,048,045 | | | $ | 1,675,102 | | | $ | 1,281,389 | |
Reconciling items: | | | | | |
Amortization of intangible assets | (102,889) | | | (96,690) | | | (82,380) | |
Stock-based compensation expense | (563,292) | | | (459,029) | | | (345,272) | |
Deferred compensation plan | (20,488) | | | 68,778 | | | (71,603) | |
Restructuring charges | (77,002) | | | (12,057) | | | (33,405) | |
Other | (15,115) | | | (14,066) | | | (13,939) | |
Total operating income | $ | 1,269,259 | | | $ | 1,162,038 | | | $ | 734,790 | |
The CODM does not use total assets by segment to evaluate segment performance or allocate resources. As a result, total assets by segment are not disclosed.
In allocating revenue to particular geographic areas, the CODM considers where individual “seats” or licenses to our products are located. Revenue is defined as revenue from external customers. Revenue and property and equipment, net, related to operations in the United States and other geographic areas are:
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
| | | | | | | | | | | | | | | | | |
| Year Ended October 31, |
| 2023 | | 2022 | | 2021 |
| (in thousands) |
Revenue: | | | | | |
United States | $ | 2,786,064 | | | $ | 2,349,766 | | | $ | 1,951,964 | |
Europe | 595,634 | | | 493,430 | | | 440,825 | |
China | 886,256 | | | 795,405 | | | 562,711 | |
Korea | 634,802 | | | 531,542 | | | 427,471 | |
Other | 939,863 | | | 911,399 | | | 821,222 | |
Consolidated | $ | 5,842,619 | | | $ | 5,081,542 | | | $ | 4,204,193 | |
| | | | | | | | | | | |
| As of October 31, |
| 2023 | | 2022 |
| (in thousands) |
Property and Equipment, net: | | | |
United States | $ | 338,260 | | | $ | 297,780 | |
Other | 219,001 | | | 185,520 | |
Total | $ | 557,261 | | | $ | 483,300 | |
Geographic revenue data for multi-regional, multi-product transactions reflect internal allocations and are therefore subject to certain assumptions and to our allocation methodology.
One customer, including its subsidiaries, accounted for 12.4%, 11.7%, and 10.6% of our consolidated revenue in fiscal 2023, 2022, and 2021, respectively. One customer accounted for 10.9% of our accounts receivable as of October 31, 2023. No customer accounted for over 10% of our accounts receivable as of October 31, 2022.
Note 18. Restructuring Charges
In the first quarter of fiscal 2023, we initiated a restructuring plan for involuntary employee terminations as part of a business reorganization (the 2023 Plan). The 2023 Plan was substantially completed in the third quarter of fiscal 2023 and total charges under the 2023 Plan were $77.0 million consisting primarily of severance costs and facility exit costs.
During fiscal 2023, we made payments of $68.3 million under the 2023 Plan. As of October 31, 2023, the payroll and related benefits liabilities of $4.2 million were recorded in accounts payable and accrued liabilities, and the remaining outstanding restructuring related liabilities of $4.5 million were recorded in other long-term liabilities in the consolidated balance sheets.
During fiscal 2022, we recorded restructuring charges of $12.1 million and made payments of $26.3 million under the 2021 restructuring plan (the 2021 Plan) initiated in the third quarter of fiscal 2021.There was no outstanding balance under the 2021 Plan as of October 31, 2022.
During fiscal 2021, we recorded restructuring charges of $33.4 million and made payments of $19.2 million under the 2021 Plan. As of October 31, 2021, $14.2 million of payroll and related benefits liabilities remained outstanding and was recorded in accounts payable and accrued liabilities in the consolidated balance sheets.
SYNOPSYS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—Continued
Note 19. Subsequent Event
In November 2023, we completed the sale of a strategic equity investment in a privately-held company, and expect to recognize a gain ranging from $50.0 million to $60.0 million in the first quarter of fiscal 2024.